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Micro/nano size particles are very useful vehicles for surface and bulk 
functionalization due to their high surface/volume ratio and their ability to encapsulate 
other agents. In this thesis, different approaches of surface and bulk functionalization 
of micro/nanoparticles for diagnosing or eliminating malignant cells were developed. 
At the same time, other important properties of particles such as the cytotoxicity and 
cell uptake were investigated after the functionalization process. 
A simple technique was first developed for preparing polymeric microparticles for 
antimicrobial applications. Poly (4-vinyl pyridine)/poly (vinylidene fluoride) 
(P4VP)/(PVDF) microparticles prepared by the phase inversion technique were used 
as the substrate. P4VP contributed the antimicrobial groups while PVDF provided the 
mechanical strength of the beads. The N-alkylation of the P4VP was carried out with 
alkyl chains of different lengths since the length of the carbon side chains has been 
shown to affect the antibacterial efficacy of pyridinium-type polymers. Two 
microorganisms, a Gram-negative bacteria Escherichia coli (E. coli) and a fungi spore 
Aspergillus niger (A. niger), were chosen to test the antimicrobial efficacy of the 
microparticles. To obtain a better understanding of the difference in efficacy against 
these two microbial species, the effect of surface pyridinium groups on cellular 
components was studied. This technique for preparing antibacterial microparticles has 
the advantages of ease of mass production and scale up, and the microparticles 
possess stability for repeated usage. 
In the second part of the work, magnetic nanoparticles were developed for the 
detection and elimination of malignant mammalian cells. For in vivo applications, the 
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particles to be introduced must be small enough, such that they do not clog the blood 
vessels through which they are guided to the target organ. A new magnetic targeted 
drug delivery carrier was developed by encapsulating magnetic Fe3O4 seeds and 
tamoxifen, a drug for human breast cancer, in a biodegradable polymer, poly(L-lactic 
acid) (PLLA), in the form of nanoparticles. These magnetic nanoparticles can also be 
used as contrast agents for magnetic resonance imaging (MRI), with which the 
distribution of the carrier can be visualized in vivo. The encapsulation of tamoxifen in 
the polymer matrix can extend the release profile over that of other reported methods. 
The anti-cancer activity of the nanoparticles was evaluated with MCF-7 breast cancer 
cells. Subsequently, a block polymer, poly(L-lactic acid)-block-poly(poly(ethylene 
glycol) monomethacrylate) (PLLA-b-PPEGMA), was synthesized for encapsulating 
the magnetic seeds, and the composite polymer-Fe3O4 nanoparticles were then surface 
functionalized with folic acid. The uptake of the folic acid functionalized 
nanoparticles by cancer cells was shown to be enhanced compared to that of 
nanoparticles without folic acid functionalization. 
Finally, a new PEGylation strategy was developed to increase the circulation time of 
magnetic nanoparticles in the blood stream via surface initiated atom transfer radical 
polymerization (ATRP). A silane initiator was first immobilized on the magnetic 
nanoparticles surface. Then, copper-mediated ATRP technique was used to graft 
polymerize poly(ethylene glycol) monomethacrylate (PEGMA) on the magnetic 
nanoparticles surface. The uptake of the PEGMA-functionalized magnetic 
nanoparticles by macrophage cells was used to evaluate the applicability of this 
technique for increasing in vivo half-life of magnetic nanoparticles. 
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Harmful cells, such as pathogenic microorganisms and malignant cells, constitute one 
of the main threats to human beings. There is an increasing need for tools capable of 
diagnosing and eliminating these cells. A great deal of ongoing research in material 
science is devoted to attaining this goal. The main research focus of this project is to 
use surface and bulk functionalization techniques to confer micro/nano particles with 
the ability to eliminate malignant cells.  
The specific aims of this Ph.D study were as follows: 
1) To prepare polymeric microbeads and investigate their antibacterial and antifungal 
efficacy in repeated applications. 
2) To develop magnetic nanoparticulate carriers for magnetic targeted drug delivery 
or folic acid-mediated cancer targeting, and explore the uptake of the carrier by 
human breast cancer cells. 
3) To develop a new strategy to PEGylate magnetic nanoparticles for increasing their 
circulation time in the body and investigate the uptake of these functionlized 
magnetic nanoparticles by macrophage cells. 
In Chapter 2, antibacterial effects of selected biocides and important factors affecting 
the biocidal activity of cationic disinfectants will be reviewed. In addition, the 
methods to synthesize and modify magnetic nanoparticles for biomedical applications 
will be reviewed. 
In Chapter 3, a simple method to prepare polymeric microbeads with 
antibacterial and antifungal properties is described. The microbeads of approximately 
spherical shape and narrow size distribution were prepared from a mixture of poly (4-
vinyl pyridine) (P4VP) and poly (vinylidene fluoride) (PVDF) by a phase inversion 
Chapter 1 
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technique and subsequently derivatized with alkyl bromides having four to ten carbon 
atoms. The quaternization of the pyridine groups into pyridinium groups confer the 
surface with highly effective and long lasting antibacterial and antifungal properties, 
as shown by the effect on Escherichia coli (E. coli) and Aspergillus niger (A. niger). 
Upon contact with the N-alkylated beads, the bacteria and fungal spores are lysed and 
intracellular constituents leach out into the medium. The efficacy of the alkyl chains 
in disrupting the cell membrane was investigated. The stability of the functional group 
and microbiocidal effectiveness of the microbeads in repeated applications was also 
assessed. 
Chapter 4 describes a new strategy for preparing a magnetic drug delivery carrier, 
tamoxifen-loaded magnetite/poly(L-lactic acid) composite nanoparticles (TMCN). 
The composite nanoparticles with an average of ~200 nm, were synthesized via a 
solvent evaporation/extraction technique in an oil/water emulsion. The 
superparamagnetic property (saturation magnetization value of ~7 emu/g) of the 
TMCN is provided by Fe3O4 seeds of ~6 nm encapsulated in the poly (L-lactic acid) 
matrix. The encapsulation efficiency of the Fe3O4 and tamoxifen as a function of the 
concentration in the organic phase was investigated. The uptake of TMCN and 
tamoxifen by MCF-7 was estimated from the intracellular iron concentration. After 4 
h incubation of MCF-7 with TMCN, significant changes in the cell morphology were 
discernible from phase contrast microscopy. Cytotoxicity assay shows that while the 
Fe3O4-loaded poly (L-lactic acid) composite nanoparticles exhibit no significant 
cytotoxicity against MCF-7, ~80% of the these cells were killed after incubation for 4 
days with TMCN. 
Chapter 5 describes the synthesis of a new polymer, poly(L-lactic acid)-block-
poly(poly(ethylene glycol) monomethacrylate) (PLLA-b-PPEGMA), and the 
Chapter 1 
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functionalization of the PLLA-b-PPEGMA nanoparticles with folic acid for targeting 
cancer cells. The synthesis of the block co-polymer was performed by ring-opening 
polymerization of lactide in bulk with a double-headed initiator, 2-hydroxyethyl 2’-
methyl-2’-bromopropionate (HMBP), followed by atom transfer radical 
polymerization (ATRP) of PEGMA using the as-synthesized polylactide with the 2-
bromo-2-methylpropionyl terminal group as initiator. The PLLA-b-PPEGMA 
nanoparticles encapsulated with Fe3O4 were prepared via a solvent 
evaporation/extraction technique in an oil/water emulsion. Using the functional 
groups of the PPEGMA the particles were then functionalized with folic acid in the 
presence of a carbodiimide. The efficiency of the folic acid functionalized particles in 
targeting cancer cells was demonstrated with MCF-7 breast cancer cells and RAW 
246.7 macrophage cells. The uptake of the nanoparticles by these cells was estimated 
from the intracellular iron concentration. The results show that folic acid on the 
nanoparticle surface increases the rate and amount of nanoparticles taken up by 
targeted cells. Thus, the PLLA-b-PPEGMA nanoparticles functionalized with cancer 
targeting ligands have good potential as a carrier for targeted drug delivery in cancer 
treatment. 
The use of magnetic nanoparticles in the blood compartment depends on specific 
requirements with respect to their plasma half-life and their final biodistribution. The 
most satisfactory strategy to minimize or delay the nanoparticle uptake by the 
mononuclear phagocyte system (MPS) is covalent anchorage of poly(ethylene glycol) 
(PEG) macromolecules onto the carrier surface. In Chapter 6, a new method to 
PEGylate magnetic nanoparticles with a dense layer of PPEGMA by ATRP is 
described. In this approach, an initiator for ATRP was first immobilized onto the 
magnetic nanoparticle surface, and PPEGMA was then grafted onto the surface of 
Chapter 1 
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magnetic nanoparticle via copper-mediated ATRP. The modified nanoparticles were 
subjected to detailed characterization using FTIR, XPS and TGA. The PPEGMA-
immobilized nanoparticles dispersed well in aqueous media. The saturation 
magnetization values of the PPEGMA-immobilized nanoparticles were 19 emu/g and 
11 emu/g after 2 and 4 h polymerization respectively, compared to 52 emu/g for the 
pristine magnetic nanoparticles. The response of macrophage cells to pristine and 
PPEGMA-immobilized nanoparticles was compared. The results showed that the 
macrophage cells are very effective in cleaning up the pristine magnetic nanoparticles. 
With the PPEGMA-immobilized nanoparticles, the amount of nanoparticles 
internalized into the cells is greatly reduced to <2 pg/cell over a 5 day period. With 
this amount of nanoparticles uptake, no significant cytotoxicity effects were observed. 
Chapter 7 gives the overall conclusion of the present work and the recommendations 






















2.1 Effects of Biocides on Bacteria 
2.1.1 Potential Targets and Effects of Biocides 
Target regions for antibacterial agents can be classified very conveniently as the cell 
wall, cytoplasmic membrane and cytoplasm. Within these broad areas of the cell a 
further division of targets can be made into those of biochemical or structural 
significance. These divisions are created for convenience only and do not represent 
mutually exclusive areas for biocide interaction. Indeed, many of the biocides 
currently in use have more than one potential target within the bacterial cell (Table 
2.1), and the strong interdependence of cellular functions cannot be ignored (Denyer 
1990). 
The focus for many agents is the cytoplasmic membrane. Interactions at this level 
frequently cause fundamental changes in both membrane structure and function. This 
has important implications for the entire cell biochemistry with memebrane disruption 
of respiration, cellular energetics, transport processes, intracellular substrate reservoirs, 
and enzyme function. 
Table 2.1 The antibacterial effects of selected biocides (Denyer 1990) 
Target 
region Damage event Consequence Biocide 
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2.1.2 Interactions between Cell Membrane and Disinfectants 
The cytoplasmic cell membrane undoubtedly is the target for many antibacterial 
agents. Interactions of bacterial membranes with biocides frequently cause 
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fundamental changes in both membrane structure and function. There are several 
different kinds of interactions (Denyer 1990): 
A. Biocides such as cetyl trimethyl ammonium bromide (CTAB) can insert its 
hydrophobic component into the phospholipid bilayer and attract negatively 
charged lipids. 
B. Phospholipids bilayers can be redistributed through the interaction with 
positively charged polymeric biguanides. 
C. Some biocides such as phenols can also displace phospholipids and thus 
reorganize membrane structure. 
D. Some biocides, especially antibiotics, can induce pore formation through 
biocide self-association. 
E. High concentrations of anionic detergents can solubilize membrane bound 
proteins. 
2.1.3 Mechanisms of Antibacterial Action of Quaternary 
Ammonium Salts 
The polymers containing quaternary ammonium salts belong to the group of 
compounds known as polycationic biocides. Quaternary ammonium salts are widely 
used as effective antibacterial agents because of their strong ability to kill bacteria. 
The target site of such cationic biocides is the cytoplasmic membrane of bacteria. The 
antibacterial mechanism of these cationic disinfectants can be summarized in the 
following seven steps (Franklin and Snow 1981; Kawabata and Nishiguchi 1988).  
A. Adsorption onto the bacterial cell surface. 
B. Diffusion through the cell wall. 
C. Binding to the cytoplasmic membrane. 
D. Disruption and disintegration of the cytoplasmic membrane. 
E. Release of electrolytes such as potassium ions and phosphate from the cell. 
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F. Release of nucleic materials such as DNA and RNA. 
G. Precipitation of the cell contents and the death of the cell. 
2.1.4 Factors Affecting Biocidal Activity 
Important factors of cationic disinfectants affecting biocidal activity are: (1) 
Electrostatic interaction between the cells and the disinfectants; (2) The hydrophobic 
chain length of the quaternary group. After diffusion through the cell walls, the 
disinfectants need to have hydrophobic or lipophilic moieties in them to facilitate their 
binding to the cytoplasmic membrane. (3) Morphological effect of disinfectants.  
2.1.4.1 Electrostatic Interaction between the Cells and the 
Disinfectants 
One of the most important physicochemical properties of bacteria is their charged 
phenomenon. In a bacterial suspension, amino acids constituting a bacterial protein on 
the cell wall may dissociate into positively charged amino groups ( 3NH
 ) and 
negatively charged carboxyl groups ( COO ). This phenomenon has much to do with 
the pH of the medium. In an acid medium with a pH value lower than the isoelectric 
point of the bacteria, there are more dissociated amino groups than carboxyl groups, 
so the bacterial cells bear positive charges. Conversely, in a medium with a pH value 
higher than the isoelectric point of the bacteria, the dissociation of amino groups is 
partially inhibited with a relative increase in the dissociated carboxyl groups, so the 
bacterial cells bear negative charges. When the pH value of a medium equals the 
isoelectric point of the bacteria, there are as many positive charges as negative 
charges on the surface of the bacterial cells making the cells exhibiting electrical 
neutrality. For example, the Gram-negative bacteria have negative charges on their 
surface in the usual neutral environment because their isoelectric point is pH 4–5 (Li 
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and Shen 2000). The electrostatic interaction between bacterial cells and positively 
charged disinfectants plays an important role in antimicrobial activities. 
Cationic polymers with quaternary ammonium or biguanide groups exhibited higher 
antimicrobial activities than corresponding low MW model compounds. The higher 
activity of polycationic compounds have been interpreted as follows: Bacterial cell 
surface is negatively charged at physiological pH and cationic disinfectants are 
positively charged at the pH. The disinfectants are adsorbed onto the cell surfaces by 
electrostatic interaction. The adsorption of polycations onto the negatively charged 
cell surfaces is expected to take place to a greater extent than that of monomeric 
cations because of the much higher charge density carried by the polycations. Binding 
to the cytoplasmic membrane is also expected to be facilitated by the polycations, 
compared with that by the monomeric cations, because of the presence of a large 
number of negatively charged species in the membrane. Thus, the disruption of 
membrane and subsequent leakage of K+ ions and other cytoplasmic constituents 
would be enhanced by the polycations. 
2.1.4.2 Hydrophobic Chain Length 
The hydrophobic chain dependence has been most frequently studied to determine the 
most potent biocides. It depends on both the chemistry (structure of the biocides) and 
biology (structure of the bacteria).  
Gilbert and co-workers evaluated the antibacterial properties of a series of alkyl 
trimethylammonium bromides against S. aureus, Saccharomyces cerevisiae, and 
Pseudomonas aeruginosa. They found that the level of activity was parabolically 
related to the N-alkyl chain length. The highest potency was achieved for C10 and 
C12 (Gilbert and Al-Taae 1985). Chen et al investigated the effect of hydrophobic 
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chain length of quaternary groups on biocidal activity against E. coli for generation 3 
dendrimer biocides. They found dendritic biocides with C10 chains tend to be the 
most effective, followed by C8 and C12 chains. Those with C14 and C16 chains are 
the least active (Chen et al. 2000). For polymeric quaternary ammonium biocides, the 
hydrophilic-lipophilic balance also influences antimicrobial properties. Tiller et al 
studied antibacterial properties against S. aureus of glass slides modified with P4VP 
that was N-alkylated with different linear alkyl bromides (Tiller et al. 2001). They 
discovered that C6 showed the highest antibacterial activity, followed by C4 and C3. 
Those slides with C10, C12 and C16 showed lower activity. Nakagawa et al. 
immobilized quaternary ammonium salts onto glass beads through silane chemistry 
(Nakagawa et al. 1984). They found that the alkyl chain length strongly affected the 
antibacterial properties against E. coli. The glass beads containing C2-C4 alkyl chains 
showed lower activity, while those with C8-C18 showed higher antibacterial 
characteristics. The glass beads with C10 alkyl chains turned out to be the most potent 
out of all the samples tested. Thus, the hydrophobic parts in these molecules play a 
significant role in determining the antibacterial properties of the polycations. The 
hydrophilic-lipophilic balance has been frequently used as a parameter to model 
antibacterial properties in quantitative analyses. 
2.1.4.3 Morphological Effect of Disinfectants 
Another concept on the mode of action of cationic biocides was proposed by 
Kanazawa et al. (Kanazawa et al. 1995). The antibacterial activity of cationic 
disinfectants was ascribed essentially to molecular organizations of cations within 
aggregates, i.e., the activity is determined by the size of aggregates and number of 
active molecules comprising the aggregate. On the basis of the new concept, the 
morphological effect of disinfectants, which are low MW phosphonium salts with 
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single and double long alkyl chains (C14), in aqueous solution on the antibacterial 
activity has been used to explain the lethal action of low MW cationic biocides. It was 
found that antibacterial activity is dependent on the size of the aggregates and there 
exists an optimal size range for the antibacterial activity of the cationic disinfectants. 
Similar facts have also been found in cationic polymeric disinfectants (Ikeda et al. 
1986). The proposed new concept can be applied to all phenomena in the activity of 
cationic biocides reported previously. 
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2.2 Magnetic Nanoparticles for Cancer Detection and Treatment 
Magnetic nanoparticles show remarkable new phenomena such as 
superparamagnetism, high field irreversibility, high saturation field, extra anisotropy 
contributions or shifted loops after field cooling. These phenomena arise from finite 
size and surface effects that dominate the magnetic behavior of individual 
nanoparticles. Frenkel and Dorfman were the first to predict that a particle of 
ferromagnetic material, below a critical particle size (<15 nm for the common 
materials), would consist of a single magnetic domain, i.e. a particle that is a state of 
uniform magnetization at any field (O'Grady 2003). The magnetization behavior of 
these particles above a certain temperature, i.e. the blocking temperature, is identical 
to that of atomic paramagnets (superparamagnetism) except that an extremely large 
moment and thus, large susceptibilities are involved. 
Magnetic nanoparticles offer some attractive possibilities in biological applications. 
Firstly, they have controllable sizes ranging from a few nanometers up to tens of 
nanometers, which places them at dimensions that are smaller than or comparable to 
those of a cell (10–100μm), a virus (20–450 nm), a protein (5–50 nm) or a gene 
(2 nm wide and 10–100 nm long). This means that they can ‘get close’ to a 
biological entity of interest. Indeed, they can be coated with biological molecules to 
make them interact with or bind to a biological entity, thereby providing a 
controllable means of ‘tagging’ or addressing it. Secondly, the nanoparticles are 
magnetic and can be manipulated by an external magnetic field gradient at a distance. 
This ‘action at a distance’, combined with the intrinsic penetrability of magnetic fields 
into human tissue, opens up many applications involving the transport and/or 
immobilization of magnetic nanoparticles, or of magnetically tagged biological 
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entities. In this way they can be made to deliver a package, such as an anticancer drug, 
or a cohort of radionuclide atoms, to a targeted region of the body, such as a tumor. 
Thirdly, the magnetic nanoparticles can be made to resonantly respond to a time-
varying magnetic field, with advantageous results related to the transfer of energy 
from the exciting field to the nanoparticle. For example, the particle can be made to 
heat up, which leads to their use as hyperthermia agents, delivering toxic amounts of 
thermal energy to targeted bodies such as tumors; or as chemotherapy and 
radiotherapy enhancement agents, where a moderate degree of tissue warming results 
in more effective malignant cell destruction. These, and many other potential 
applications, are made available in biomedicine as a result of the special physical 
properties of magnetic nanoparticles. 
2.2.1 Basic Concepts of Magnetism 
If a magnetic material is placed in a magnetic field of strength H, the individual 
atomic moments in the material contribute to its overall response. The magnetic 
induction is given as:  
)(0 MHB    
where 0  is the permeability of free space, and the magnetization V/mM   is the 
magnetic moment per unit volume, where m is the magnetic moment on a volume V 
of the material. All materials are magnetic to some extent, with their response 
depending on their atomic structure and temperature. They may be conveniently 
classified in terms of their volumetric magnetic susceptibility, χ, where 
H,M   
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describes the magnetization induced in a material by H. In SI units χ is dimensionless 
and both M and H are expressed in Am-1. Most materials display little magnetism, and 
even then only in the presence of an applied field; these are classified either as 
paramagnets, for which χ falls in the range 10-6-10-1, or diamagnets, with χ in the 
range -10-6 to -10-3 (Figure 2.1). However, some materials exhibit ordered magnetic 
states and are magnetic even without a field applied; these are classified as 
ferromagnets, ferrimagnets and antiferromagnets, where the prefix refers to the nature 
of the coupling interaction between the electrons within the material. This coupling 
can give rise to large spontaneous magnetizations; in ferromagnets M is typically 104 
times larger than would appear otherwise. 
The susceptibility in ordered materials depends not just on temperature, but also on H, 
which gives rise to the characteristic sigmoidal shape of the M–H curve, with M 
approaching a saturation value at large values of H. Furthermore, in ferromagnetic 
and ferrimagnetic materials one often sees hysteresis, which is the irreversibility in the 
magnetization process that is related to the pinning of magnetic domain walls at 
impurities or grain boundaries within the material, as well as to intrinsic effects such 
as the magnetic anisotropy of the crystalline lattice. This gives rise to open M–H 
curves, called hysteresis loops. The shape of these loops is determined in part by 
particle size: in large particles (of the order micron size or more) there is a multi-
domain ground state which leads to a narrow hysteresis loop since it takes relatively 
little field energy to make the domain walls move; while in smaller particles there is a 
single domain ground state which leads to a broad hysteresis loop. At even smaller 
sizes (of the order of tens of nanometres or less) one can see superparamagnetism, 
where the magnetic moment of the particle as a whole is free to fluctuate in response 









relative to each other. This leads to the anhysteretic, but still sigmoidal, M–H curve 
shown in Figure 2.1. In most cases superparamagnetic particles (usually Fe2O3 and 
Fe3O4) are of interest for in vivo applications, as they do not retain any magnetism 
after removal of the magnetic field. This is important as large domain magnetic and 











Figure 2.1 Magnetic responses associated with different classes of magnetic 
material. 
2.2.2 Synthesis Methods of Magnetic Nanoparticles 
Particle size and the structure to produce magnetic materials with a defined magnetic 
response are very important for a specific biomedical application. Size and structural 










three most common approaches used to produce magnetic nanoparticles, which are 
physical vapor deposition, mechanical attrition, and chemical routes from solution. In 
both the vapor phase deposition and solution chemical routes, the particles are 
assembled from individual atoms to form nanoparticles. Alternatively, mechanical 
attrition involves the fracturing of larger coarse-grained materials to form 
nanostructures. 
In this section, an overview of the chemical synthesis and processing of 
nanostructured particles is presented. Chemical routes from solution often provide the 
best method for production of nanoparticles due to enhanced homogeneity from the 
molecular level design of the materials and, in many cases, cost effective bulk 
quantity production. Solution routes also allow control of particle size and size 
distribution, morphology, and agglomerate size through the individual manipulation 
of the parameters that determine nucleation, growth, and coalescence. Surface 
modification of the particles during synthesis or post-synthesis is easily accomplished, 
providing additional functionality to the nanoparticles. 
2.2.2.1 Precipitation 
One of the oldest techniques for the synthesis of nanoparticles is the precipitation of 
products from solutions. In precipitation reactions, the metal precursors are dissolved 
in a common solvent (such as water) and a precipitating agent is added to form an 
insoluble solid. There are two main methods for the synthesis of magnetite spherical 
particles in the nanometer range in solution. In the first, ferrous hydroxide 
suspensions are partially oxidized with different oxidizing agents (Sugimoto and 
Matijevic 1980). For example, spherical magnetite particles of narrow size 
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distribution with mean diameters between 30 and 100 nm can be obtained from a 
Fe(II) salt, a base and a mild oxidant (nitrate ions) (Sugimoto and Matijevic 1980). 
The other method utilizes an alkaline solution to precipitate stoichiometric mixtures of 
ferrous and ferric ions in aqueous media. The first controlled synthesis of magnetic 
nanoparticles utilising this alkaline precipitation technique was performed by Massart 
(Massart 1980). Fe3O4 nanoparticles were precipitated from FeCl3 and FeCl2 at a 
slightly basic pH of 8.2. These particles were roughly spherical, 10 nm in diameter 
with size distribution greater than 50% deviation from the mean. Through size 
selection titration the size distribution can be reduced to less than 5% deviation from 
the mean. An aging step was found necessary to yield spherical magnetite particles 
homogeneous in size (Massart and Cabuil 1987; Liao and Chen 2001). The 
concentration of the metal species present in the initial reaction mixture was shown to 
have a pronounced effect on the overall nanoparticle size. Unfortunately, low 
concentrations resulted in limited particle growth, although the resultant particles 
were generally more uniform in size. As the metal concentration was increased, there 
was increased particle growth with a subsequent loss of size uniformity (Massart and 
Cabuil 1987). In addition, it has been shown that by adjusting the pH and the ionic 
strength of the precipitation medium, it is possible to control the mean size of the 
particles over one order of magnitude (from 15 to 2 nm) (Jolivet 2000). The size 
decreases as the pH and the ionic strength in the medium increases (Jolivet 2000). 
Both parameters affect the chemical composition of the surface and consequently, the 
electrostatic surface charge of the particles. The major advantage of precipitation 




Surfactant molecules when in solution spontaneously form spherical aggregates called 
micelles or microemulsions. Direct micelles (oil-in-water O/W) have the hydrophilic 
portion of the surfactant on the outside of the aggregate exposed to polar solvent, 
while reverse or inverse micelles (water-in-oil W/O) have the hydrophobic portion on 
the outside exposed to a non-polar solvent. In the case of reverse micelles formed in 
hydrocarbon, water can be readily solubilised forming a ‘water pool’ where size is 
characterized by a water/surfactant ratio. In this fashion, the water pools within 
micelles forms thermodynamically stable liquid media. In these systems, fine 
microdroplets of the aqueous phase are trapped within assemblies of surfactant 
molecules dispersed in a continuous oil phase. The surfactant-stabilized microcavities 
(typically in the range of 10 nm) provide a confinement effect that limits particle 
nucleation, growth, and agglomeration. 
Sodium dioctylsulphosuccinate (AOT) was the first and most characterized surfactant 
system used in the synthesis of magnetic nanoparticles. Other systems, such as 
cetyltrimethylammonium bromide (CTAB), sodium dodecylsulphate (SDS), and 
polyethoxylates (Igepal, Brij, Tween, C12E5) have also been used, and more are being 
developed to optimize morphology and chemical parameters.  
The first magnetic nanoparticles formed in micelles were from the oxidation of Fe2+ 
salts to form Fe3O4 and α-Fe2O3 (Inouye et al. 1982). This reaction was carried out in 
an AOT/isooctane system and formed spherical nanoparticles with surprisingly tight 
size distributions of less than 10%. Later, other reactions using hydrogen peroxide 
were used to form MnFe2O4 (Carpenter et al. 1999). The initial reaction conditions not 
only controlled the particle size, but also the cation occupancy.  
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Pileni and co-workers prepared nanosized magnetic particles with average sizes from 
4 to 12 nm and standard deviation ranging from 0.2 to 0.3 using microemulsions 
(Feltin and Pileni 1997). A ferrous dodecyl sulfate, Fe(DS)2, micelle solution was 
used to produce nanosized magnetic particles whose size is controlled by the 
surfactant concentration and by temperature. Magnetite nanoparticles around 4 nm in 
diameter have been prepared by the controlled hydrolysis with ammonium hydroxide 
of FeCl2 and FeCl3 aqueous solutions within the reverse micelle nanocavities 
generated by using AOT as surfactant and heptane as the continuous oil phase 
(Lopezquintela and Rivas 1993). 
Carpenter and co-workers prepared iron particles coated by a thin layer of gold via a 
microemulsion (Carpenter 2001). The gold shell protects the iron core against 
oxidation and also provides functionality, making these composites applicable in 
biomedicine. The reverse micelle reaction was carried out using CTAB as the 
surfactant, octane as the oil phase, and aqueous reactants as the water phase 
(Boutonnet et al. 1982). The metal particles were formed inside the reverse micelle by 
the reduction of a metal salt using sodium borohydride. The sequential synthesis 
offered by reverse micelles was utilized to first prepare an iron core by the reduction 
of ferrous sulfate by sodium borohydride. After the reaction has been allowed to go to 
completion, the micelles within the reaction mixture were expanded to accommodate 
the shell using a larger micelle containing additional sodium borohydride. The shell 
was formed using an aqueous hydrogen tetrachloroaurate solution (Viau et al. 1994). 
2.2.2.3 Polyols 
Preparation of uniform nanoparticles from a polyol solution is a very promising 
technique that could be used for biomedical applications such as magnetic resonance 
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imaging. Fine metallic particles can be obtained by reduction of dissolved metallic 
salts and direct metal precipitation from a solution containing a polyol (Sugimoto 
2000). Nanocrystalline powders such as Co, Ni, Cu, Ru, Rh, Pd, Ag, Sn, Re, W, Pt, 
Au, (Fe,Cu), (Co,Cu), (Co,Ni), and (Ni,Cu) were synthesised using different salt 
precursors by this method (Toneguzzo et al. 1999; Feldmann 2001). The polyol 
technique has also been used for the synthesis of other materials such as Fe-based 
alloys (Viau et al. 1996a; Viau et al. 1996b), which could be used for biomedical 
applications. 
In the polyol method, the liquid polyol takes on the role of solvent of the metal 
precursor, reducing agent, and in some cases as a complexing agent for the metallic 
cations. The metal precursor such as oxides, nitrates, and acetates can be either 
dissolved or suspended in a diol, such as ethylene glycol or diethylene glycol. The 
reaction mixture is stirred and heated to the reflux temperature of the polyol for less 
reducible metals. During the reaction, the metal precursors become solubilised in the 
diol, form an intermediate, and then are reduced to form metal nuclei, which form 
metal particles. By controlling the kinetic of the precipitation, non-agglomerated 
metal particles with well-defined shape and size can be obtained. Heterogeneous 
nucleation via adding foreign nuclei or forming foreign nuclei in situ can be 
introduced to control the average size of the metal particles. In this way, nucleation 
and growth steps can be completely separated and uniform particles result. 
Iron particles around 100 nm can be obtained by disproportionation of ferrous 
hydroxide in organic media (Fievet et al. 1989). Fe(II) chloride and sodium hydroxide 
reacts with ethylene glycol (EG) or PEG and the precipitation occurs in a temperature 
range as low as 80 – 100˚C. Furthermore, iron alloys can be obtained by 
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coprecipitation of Fe, Ni, and/or Co in EG and PEG. Monodispersed quasispherical 
and non-agglomerated metallic particles with mean size around 100 nm have been 
obtained without seeding (homogeneous nucleation) while particles between 50 and 
100 nm have been obtained using Pt as the nucleating agent (heterogeneous 
nucleation). Whereas FeCo particles are formed by agglomerates of Fe and Co 
primary particles produced over different lengths of time, spherical FeNi particles 
present good homogeneity as a result of concomitant Fe and Ni formation and growth 
by the aggregation of nm-sized primary particles (Viau et al. 1996b). 
Polymer protected bimetallic clusters were also formed using a modified polyol 
process (Saravanan et al. 2001). The modification included addition of other solvents 
and sodium hydroxide. In the synthesis of (Co,Ni) with average diameters between 
150 and 500 nm, PVP and ethylene glycol were mixed with cobalt and nickel acetate 
with PVP. The glycol and organic solvents were removed from solution by rinsing in 
acetone or filtration. The P4VP covered particles were stable in air for months. 
Compared to aqueous methods, the polyol approach resulted in the synthesis of 
metallic nanoparticles protected by surface adsorbed glycol, thus minimizing 
oxidation. The use of non-aqueous solvent such as polyol also further reduced the 
problem of hydrolysis of fine metal particles which often occurred in the aqueous case. 
By modifying the polyol method with the addition of water to act more like a sol-gel 
reaction (forced hydrolysis), oxides can be prepared (Feldmann 2001; Poul et al. 
2003). For example, 6 nm CoFe2O4 was prepared by the reaction of ferric chloride 
and cobalt acetate in 1,2-propanediol with the addition of water and sodium acetate. 
Soluble γ-Fe2O3 nanoparticles can be prepared using a similar method as that for 
Chapter 2 
24 
CoFe2O4, however an amine capping agent (n-octylamine) must be added to the 
solution (Rajamathi et al. 2002). 
2.2.2.4 High-temperature Decomposition of Organic Precursors 
One of the simplest methods to prepare nanoparticles is the decomposition of 
organometallic precursors. This decomposition may be driven by heat (thermolysis), 
light (photolysis), or sound (sonolysis). The decomposition of iron precursors in the 
presence of hot organic surfactants has yielded markedly improved samples with good 
size control, narrow size distribution and good crystallinity of individual and 
dispersible magnetic iron oxide nanoparticles. Biomedical applications like magnetic 
resonance imaging, magnetic cell separation or magnetorelaxometry strongly depend 
on particle size and thus magnetic nanoparticles produced by this method could be 
potentially used for these applications. 
For example, injecting solutions of FeCup3 (Cup: N-nitrosophenylhydroxylamine) in 
octylamine into long chain amines at 250–300˚C yields nanocrystals of maghemite 
(Rockenberger et al. 1999). These nanocrystals range from 4 to 10 nm in diameter, are 
crystalline, and are dispersable in organic solvents. Hyeon and co-workers have also 
been able to prepare monodispersed maghemite nanoparticles by a non-hydrolytic 
synthetic method (Hyeon et al. 2001). For example, to prepare maghemite 
nanoparticles of 13 nm, Fe(CO)5 was injected into a solution containing surfactants 
and a mild oxidant (trimethylamine oxide). 
Recently, Sun and Zeng have been able to prepare monodispersed MFe2O4 (M=Fe, Co, 
Mn) nanoparticles with sizes from 3 to 20 nm by the high-temperature (up to 305 ˚C) 
reaction of metal acetylacetonate in phenyl ether in the presence of alcohol, oleic acid, 
and oleylamine (Sun et al. 2004). In particular, the size of the oxide nanoparticles can 
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be controlled by varying the reaction temperature or changing metal precursors. 
Magnetite nanoparticles around 4 nm were obtained by the thermal decomposition of 
the iron precursor; larger monodispersed nanoparticles up to 20 nm in diameter can be 
synthesized by seed-mediated growth using the smaller nanoparticles as seeds. These 
magnetic MFe2O4 nanoparticles are dispersable in organic solvents. Dispersions of 
magnetic MFe2O4 nanoparticles, especially magnetite (Fe3O4) nanoparticles, have 
been used widely not only as ferrofluids in sealing, oscillation damping, and position 
sensing but also as promising candidates for biomolecule tagging, imaging, sensing, 
and separation. The hydrophobic nanoparticles can be transformed into hydrophilic 
ones by adding bipolar surfactants, and aqueous nanoparticle dispersion is readily 
made. 
2.2.3 Functionalization Magnetic Nanoparticles for Biomedical 
Applications 
Functionalization of magnetic nanoparticles with appropriate molecules provides 
particles with important properties that bare uncoated particles lack. The advantages 
of functionalized magnetic nanoparticles include: decreased interaction of magnetic 
nanoparticles with tissues or organs, using for example PEG; specifically binding to 
target cell populations using for example antibodies or receptor agonists; improved 
dispersibility, chemical stability, and reduced toxicity. Some of the most promising 
methods for the functionalization of magnetic nanoparticles that could be useful in 
biomedical applications are summarized in this section. 
2.2.3.1 Coprecipitation 
Modifications of the second coprecipitation method for preparing magnetic 
nanoparticles in section 2.2.2.1 allow for the synthesis of biocompatible magnetic 
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nanoparticles in the presence of dextran or any other substance and thus make this 
method especially appropriate for in vivo applications (Palmacci and Josephson 1993; 
Pradhan et al. 2007). In fact, this is the most common method used to obtain the 
commercial MRI contrast agents based on magnetic nanoparticles. For example, 
nanosized magnetic particles are obtained by transferring an acidic iron(II)/iron(III) 
salt solution into iron(II,III)-carbonate by adding equivalent amounts of alkaline 
carbonate, followed by thermal oxidation (Bergemann 1996). The size of the particles 
can be controlled by the thermal reaction velocity and concentration of the iron salts. 
Thus, small diameters in the range of 20-100 nm can be obtained by timely separation 
of iron (II,III)-carbonate at temperatures of 5-10˚C and subsequent heating. Larger 
particles of 100-1000 nm were obtained at reaction temperatures of 60-100˚C and 
faster conduction of iron(II,III)-carbonate to iron(II,III)-hydroxide. After surplus salts 
have been removed, the particles can be stabilized with water soluble polysaccharide 
or synthetic polymer derivatives. Magnetic particles coated with starch can retain their 
dispersion stability in the pH range of 3–12 and also in high salt concentrations 
(Bergemann et al. 1999). 
2.2.3.2 Encapsulation Method 
Encapsulation of inorganic particles into organic polymers enhances the particles’ 
compatibility with organic ingredients, reduces susceptibility to leaching, and protects 
the particle surfaces from oxidation. Consequently, encapsulation improves 
dispersibility, chemical stability, and reduces toxicity. A number of polymerization-
based methods have been employed to produce particles that consist of solid cores 
coated with a shell of polymeric materials. These include monomer adsorption onto 
particles followed by subsequent polymerization, heterocoagulation-polymerization, 
and emulsion polymerization. The first approach is one of the most frequently 
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employed to achieve polymer coatings on solid particles. The polymerization reaction 
can be either catalyzed by an initiator to promote the process or by the colloidal 
particles themselves. 
2.2.3.3 Deposition Methods 
Inorganic and hybrid coatings (or shells) on colloidal templates have been prepared by 
precipitation and surface reactions. By the adequate selection of the experimental 
conditions, mainly the nature of the precursors, temperature, and pH, this method can 
give uniform, smooth coatings, and therefore lead to monodispersed spherical 
composites. Using this technique submicrometre sized anionic polystyrene (PS) 
lattices have been coated with uniform layers of iron compounds by ageing, at 
elevated temperature, dispersions of the polymer colloid in the presence of aqueous 
solutions of ferric chloride, urea, hydrochloric acid, and polyvinylpyrrolidone (Shiho 
et al. 2000). 
One of the most promising techniques for the production of superparamagnetic 
composites is the layer-by-layer (LBL) self-assembly method. This method was firstly 
developed for the construction of ultrathin films and further developed by Caruso et al 
for the controlled synthesis of novel nanocomposites core-shell materials and hollow 
capsules (Caruso et al. 2001). It consists of the stepwise adsorption of charged 
polymers or nanocolloids and oppositely charged polyelectrolytes onto flat surfaces or 
colloidal templates, exploiting primarily electrostatic interactions for layer buildup. 
Using this strategy, colloidal particles have been coated with alternating layers of 
polyelectrolytes, nanoparticles, and proteins. Thunemann et al have demonstrated that 
superparamagnetic iron oxide nanoparticles (SPIO) prepared in aqueous solution were 
stabilized with polymers in layer-by-layer deposition method (Thunemann et al. 
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2006). The first layer around the maghemite core is formed by poly(ethylene imine) 
(PEI), and the second one is formed by poly(ethylene oxide)-block-poly(glutamic 
acid) (PEO-PGA) (Thunemann et al. 2006). The hydrodynamic diameter of the 
particles increases stepwise from Dh = 25 nm (parent) via 35 nm (PEI) to 46 nm (PEI 
plus PEO-PGA) due to stabilization. This is accompanied by a switching of their ξ-
potentials from moderately positive (+28 mV) to highly positive (+50 mV) and finally 
slightly negative (-3 mV). By contrast, the polydispersity indexes of the particles 
remain constant (ca. 0.15). The coated maghemite nanoparticles were tested to be 
stable in water and in physiological salt solution for longer than 6 months. This 
method could be used for biomedical applications because the coating of particles 
with poly(ethylene oxide)s inhibits their uptake by the reticuloendothelial system. 
This technique (often referred to as PEGylation) is under intensive investigation. 
Furthermore, magnetic nanoparticles can also be used as one layer deposited on 
submicrometre-sized particle surface by layer-by-layer method. Caruso et al have 
reported the fabrication method of magnetic composite core-shell particles and hollow 
spheres with tailored dimensions and compositions by layer-by-layer strategy. 
Composite particles were prepared by coating submicrometer-sized anionic 
polystyrene (PS) lattices with magnetite nanoparticle layers alternately adsorbed with 
polyelectrolyte from aqueous solution (Caruso et al. 2001). Hollow, intact magnetic 
spheres were obtained by calcination of the core-shell particles at elevated 
temperature. Furthermore, composite hollow spheres were prepared by calcination of 
PS lattices coated with multilayers of silica and Fe3O4 nanoparticles. These 
nanoengineered colloidal particles may potentially find applications as delivery 
systems, or in diagnostics, where the particles can be directed by application of an 
external magnetic field. 
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2.2.3.4 Surface Initiated Polymerization Processes 
Tethering of polymer chains onto a solid surface could be by physisorption or covalent 
attachment. Physisorption is a reversible process and is achieved by the self-assembly 
of polymeric surfactants or end-functionalized polymers on a solid surface. The 
surface grafting density and all other characteristic dimensions of the structure are 
controlled by thermodynamic equilibrium. 
Covalent attachment can be accomplished by either “grafting to” or “grafting from” 
approaches. ‘Grafting-to’ means that end-functionalized polymer chains are bound 
at one end via chemical reactions to the surface or to surface-bound linker molecules. 
The “grafting to” technique has been successfully used to immobilized iron oxide 
with PEG for biocompatibility (Zhang et al. 2002; Kohler et al. 2004). One intrinsic 
problem of grafting-to methods is that the bound polymer restricts the diffusion of 
further chains to the surface, resulting in generally low grafting densities. 
The “grafting from” approach is a more promising method in the synthesis of polymer 
brushes with a high grafting density and high stability of polymer layer (Zhao and 
Brittain 2000). In the ‘grafting-from’ approach the polymer chains are grown from 
initiators bound to the surface. Typical initiators for free radical polymerizations are 
azo- and peroxide compounds, which are cleaved to form reactive radicals under the 
conditions of the polymerization reactions. In grafting-from processes, only relatively 
small monomer molecules have to diffuse to reaction sites at the end of the growing 
chains. As a consequence, a higher density of grafted chains can be reached. A 
drawback of grafting-from techniques based on free radical polymerizations is the low 
homogeneity in the obtained chain length, caused by difficulties in controlling the 
propagation and termination of the polymerization reaction. However, progress in 
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polymer synthesis techniques makes it possible to produce polymer chains with 
controllable lengths. Living radical polymerization schemes such as nitroxide 
mediated polymerization, atom transfer radical polymerization (ATRP), reverse 
ATRP or reversible addition-fragmentation chain transfer (RAFT) have been used 
resulting in a significantly lower polydispersity (Matyjaszewski et al. 1999; 
Yamamoto et al. 2003; Yu et al. 2005; Ramakrishnan et al. 2006). 
MnFe2O4 and Fe2O3 and polystyrene core/shell nanoparticles have been synthesized 
via one of the “grafting from” technique-ATRP (Vestal and Zhang 2002; Wang et al. 
2003). The linear polymeric molecules attach to the surface of metal oxide cores 
through linker molecules, the initiator, via a COOH  group. This noncovalent 
linkage cannot offer a permanent linkage for the hydrophilic polymers. In a biological 
system, the hydrophilic polymer chains will be extended, and a dynamic exchange 
between the polymeric chain and other competing molecules possessing a COOH  
such as peptides and amino acids in the biological system could lead to the 
dissociation of the polymeric chain from the core surfaces. To solve this problem, 
divinylbenzene was employed for cross-linking the linear polymer chain to improve 
the stability of the core/shell nanoparticles (Li et al. 2004). 
2.2.4 Magnetic Nanoparticles for Biomedical Applications 
2.2.4.1 Magnetic Targeted Drug Delivery 
Proposed in the 1970s by Widder et al. (Widder et al. 1978), the concept of magnetic 
targeting is to inject a magnetically susceptible material coated with a drug-laden 
matrix and then to use an externally placed magnet to guide the drug matrix to the 
targeted site. Magnetic drug delivery by particulate carriers is a very efficient method 
of delivering a drug to a localized disease site. Very high concentrations of 
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chemotherapeutic or radiological agents can be achieved near the target site, such as a 
tumor, without any toxic effects to normal surrounding tissue or to the whole body. In 
magnetic targeting, a drug or therapeutic radioisotope is bound to a magnetic 
compound, injected into a patient’s blood stream, and then stopped with a powerful 
magnetic field in the target area (Figure 2.2) (Hafeli et al. 1997). Depending on the 
type of drugs, it is then slowly released from the magnetic carriers (e.g. release of 
chemotherapeutic drugs from magnetic microspheres) or confers a local effect (e.g. 
irradiation from radioactive microspheres; hyperthermia with magnetic nanoparticles). 
It is thus possible to replace large amounts of freely circulating drug with much lower 
amounts of drug targeted magnetically to localized disease sites, reaching effective 
and up to several-fold increased localized drug levels. 
 
Figure 2.2 Schematic drawing of the setup for magnetic targeting 
 
The first clinical cancer therapy trial using magnetic microspheres (MMS) was 
performed by Lubbe et al. in Germany for the treatment of advanced solid cancer in 
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14 patients (Lubbe et al. 1996a; Lubbe et al. 1996c; Lubbe et al. 2001). They use a 
ferrofluid (particle size 100 nm). The particles were coated with starch derivatives 
together with anionic endstanding phosphate groups to stabilize the magnetic particles 
and to enable for ion-exchange binding with 4’-epidoxorubicin. The Phase I study 
clearly showed the low toxicity of the method and the accumulation of the MMS in 
the target area. However, MRI measurements indicated that more than 50% of the 
MMS had ended up in the liver. This was likely due to the particles’ small size and 
low magnetic susceptibility which limited the ability to hold them at the target organ. 
Alexiou et al. investigated the biodistribution of magnetic particles loaded with 
mitoxantrone (Figure 2.3) (Alexiou et al. 2000; Alexiou et al. 2003). They found the 
concentration of the ferrofluids in the tumor region was much higher than in the 
normal organ. In contrast to systemic chemotherapy, a much higher concentration of 
mitoxantrone in the tumor and the peritumoral area was seen with only 50% and 20% 
of the normal dose. 
 





Goodwin et al have demonstrated that so-called magnetic targeted carriers (MTC) 
(FeRx Incorporated, San Diego, CA) could be targeted and retained at a region of 
interest in a swine model. After intraarterial infusion MTCs did not redistribute after 
removal of the magnetic field (Goodwin et al. 1999). MTCs were formed in a high-
energy grinding process in which activated carbon was incorporated into metallic iron 
powder to produce microparticle composites with a 75:25, Fe:C ratio, and the 
resulting particles ranged from 0.5 to approximately 5  m. The chemotherapeutic 
agent doxorubicin was adsorbed on the activated carbon component of the carrier 
(Rudge et al. 2000; Rudge et al. 2001). They treated 32 patients and were able to 
super-selectively (i.e. well directed) infuse up to 60 mg of doxorubicin in 600 mg 
MMS with no treatment-related toxicity (Johnson et al. 2002). The firm started a large 
phase I/II trial for the treatment of hepatocellular carcinoma in China, Korea, and the 
US. Current preclinical research is investigating the use of magnetic particles loaded 
with different chemotherapeutic drugs such as mitoxantrone, mitomycin C, etoposide, 
paclitaxel or oxaliplatin. 
2.2.4.2 Contrast Agents for Magnetic Resonance Imaging 
Imaging of soft tissue structure of the musculoskeletal system has become the domain 
of MRI due to its superiority over other imaging techniques. The technique measures 
changes in the magnetization of hydrogen protons in water molecules sitting in a 
magnetic field after a pulse of radio frequencies has hit them. Protons from different 
tissues react differently, giving a picture of anatomical structures. These images can 
be enhanced by adding ‘contrast agents’ which sharpen the contrast by affecting 
the behaviour of protons in their proximity (Lok 2001). In standard clinical MRI scans 
contrast agents travel through the bloodstream and tissues, increasing contrast 
wherever they go. Although the more commonly used MR contrast media are 
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gadolinium (Gd) chelates, these tend to be non-specific with rapid accumulation in the 
liver, thus they only allow a short time imaging window (Kubaska et al. 2001). 
Iron oxide crystals used as MR contrast agents are extremely small (<50 nm); because 
of their small size, individual crystals usually contain a single magnetic domain. 
Similar to ferromagnetic materials, single-domain particles align their magnetic 
moments along an external field. As a result, magnetic susceptibility in a system of 
such particles usually far exceeds the susceptibility of paramagnetic materials. In their 
natural state the magnetic moments of these domains are oriented randomly, but in the 
presence of an external magnetic field, magnetic moments are aligned along the field 
significantly altering the local magnetic field in the specimen. To date a wide variety 
of particles have been produced, differing in size (hydrodynamic particle size varying 
from 10 to 500 nm) and type of coating material used (such as dextran, starch, 
albumin, silicones, poly(ethyleneglycol)) (Babes et al. 1999). They tend to be 
classified in two main groups according to their size, as this affects plasma half-life 
and biodistribution. The first group are termed SPIOs (superparamagnetic iron oxides) 
where nanoparticles have a size greater than 50 nm (coating included) and the second 
type termed USPIOs (ultrasmall superparamagnetic iron oxides) where nanoparticles 
are smaller than 50 nm. 
The use of magnetic nanoparticles for MRI in the blood compartment depends on 
specific requirements with respect to their plasma half-life and their final 
biodistribution as they are exposed to the mononuclear phagocyte system (MPS) (or 
reticuloendothelial system). The reticuloendothelial system is defined as the cell 
family comprising bone marrow progenitors, blood monocytes and tissue 
macrophages (such as Kupffer cells in the liver). These macrophages are widely 
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distributed and strategically placed in many tissues of the body to recognize and clear 
senescent cells, invading micro-organisms or particles (Moghimi et al. 2001). The 
first step of the clearance mechanism is the opsonization process. Opsonins are 
circulating plasma proteins (various subclasses of immunoglobulins, complement 
proteins, fibronectin, etc.), which adsorb themselves spontaneously onto the surface of 
any invading entity. They are capable of interacting with the specialized plasma 
membrane receptors on monocytes and macrophages, thus promoting particle 
recognition by these cells. The second step consists of the endocytosis/phagocytosis 
of the particles by the circulating monocytes or the fixed macrophages, leading to 
their elimination from circulation and their simultaneous concentration in organs with 
high phagocytic activity (Schafer 2002). The effect of physico-chemical properties on 
the opsonization process is that the smaller, the more neutral and the more hydrophilic 
the carrier surface, the longer its plasma half-life. Concerning the size effect, this 
indicates that surface curvature changes may affect the extent and/or the type of 
opsonin adsorption. The most satisfactory strategy to minimize or delay the 
nanoparticle uptake by the MPS is covalent anchorage of PEG macromolecules onto 
the carrier surface. Such a route is well-known in galenical pharmacology where 
drugs (small molecules, but also peptides, proteins, antibodies and oligonucleoides) 
are conjugated to PEG macromolecules in order to improve their circulation lifetime, 
bioavailability and decrease their immunogenicity, renal clearance rate and dosing 
frequency. This process is so widely used that it is called ‘PEGylation’. PEG has been 
shown to be the most effective polymer for suppressing protein adsorption, the 




2.2.4.3 Magnetically Induced Hyperthermia Treatment for 
Malignant Cells 
The most ideal therapy in cancer treatment is preferential killing of cancer cells 
without damaging normal cells. The idea of hyperthermia as a treatment for cancer 
comes from the observations that exposure of cancer tissues to elevated temperatures 
(above 42°C) generally reduces viability of cancer cells and increases their sensitivity 
to radiation and chemotherapy (Chan et al. 1993). Ultrasonic or microwave treatments 
have been used as means of heat delivery, but recently researchers are increasingly 
focused on the injection of magnetic fluids directly into the tumor sites, or into the 
blood supplying the tumor. In this strategy, magnetic particles are firstly dispersed 
throughout the target tissue, and an alternating magnetic field of sufficient strength 
and frequency is then applied to cause the particles to heat up. This heat conducts into 
the immediate surrounding diseased tissue whereby, if the temperature can be 
maintained above the therapeutic threshold of 42˚C for 30 min or more, the cancer is 
destroyed (Moroz et al. 2002; Berry and Curtis 2003; Pankhurst et al. 2003; Mornet et 
al. 2004).  
There are two approaches in magnetically mediated tumor heating. The first one is 
called magnetic hyperthermia and involves the generation of temperatures up to 43-47 
˚C by the particles. This treatment is adopted in conjunction with chemotherapy or 
radiotherapy, as it also renders the cells more sensitive (Hilger et al. 2002; Ito et al. 
2004). The second technique is called magnetic thermoblation, and uses temperatures 
of 43-55 ˚C that have strong cytotoxic effects on both tumor and normal cells (Jordan 
et al. 1996; Hilger et al. 2001; Johannsen et al. 2004). The reason for this use of 
higher temperatures is due to the fact that about 50% of tumors regress temporarily 
after hyperthermic treatment with temperatures up to 44 ˚C, therefore investigators 
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prefer to use temperatures up to 55 ˚C (Hilger et al. 2001). The problem of deleterious 
effects on normal cells is reduced by intratumoural injection of the particles (Berry 










CHAPTER 3 ANTIBACTERIAL AND 
ANTIFUNGAL EFFICACY OF SURFACE 





Free halogen, ozone and many soluble disinfectants are used for sterilizing water and 
wastewater. However, with these soluble disinfectants, there is a problem of residual 
toxicity of the agents; for example, chlorine reacts with organic substances in the 
water to yield halomethane analogues that are suspected of being carcinogenic. In 
order to kill bacteria effectively and to prevent residual toxicity of the agents, 
insoluble polymeric materials with antimicrobial groups, such as N-halamine, phenol 
derivatives, quaternary ammonium groups and phosphonium groups (Worley and Sun 
1996; Nonaka et al. 1997; Grapski and Cooper 2001; Kenawy et al. 2002; Sun and 
Sun 2002a; Sun and Sun 2002b; Kenawy and Mahmoud 2003; Popa et al. 2003; Chen 
et al. 2004b; Chen et al. 2004a), were developed. The application of antimicrobial 
polymer minimizes the environmental problems accompanying the conventional 
agents. In addition, polymers have a higher density of biologically active groups than 
their corresponding oligomers, which in turn accounts for the higher antimicrobial 
activities exhibited by the polymers. For example, cationic polymers are expected to 
bind more easily to the cell membrane and facilitate the disruption of the membrane 
of the microorganism because of the higher charge density carried by the polycations 
(Tashiro 2001; Lin et al. 2002b). Hence, insoluble antimicrobial polymers have good 
potential for application in the areas related to biomedical, environmental protection 
and water treatment. 
Our group has previously carried out surface functionalization of polymeric substrates 
with pyridinium-type polymers and viologen moieties to impart antibacterial property 
to the substrate (Cen et al. 2003; Shi et al. 2005). The primary focus of these works 
had been on the development of the surface functionalization technique and the 
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antibacterial assay was carried out for E. coli only. Since films have limited surface 
area for functionalization, in the present work, we investigate the use of polymeric 
microbeads to achieve a high specific surface area which in turn would facilitate the 
immobilization of a high concentration of antimicrobial groups. The preparation of 
beads for antibacterial purposes has received considerable attention recently. It has 
been shown that functionalization of preformed polystyrene beads with N-halamine 
groups conferred the beads with effective biocidal properties (Chen et al. 2004a; Chen 
et al. 2004b). These N-halamine functionalized beads were reported to kill bacteria by 
transferring the oxidative halogen atoms from the polymer to the microbial cells. 
Since the halogen atoms are lost, the biocidal efficacy has to be restored by exposure 
to a source of free chlorine. In another method, polymeric beads bearing phenol 
derivatives were used which avoided the release of the functional groups (Nonaka et 
al. 1997). However, this method involves suspension copolymerization which resulted 
in beads with wide size distribution. The beads were then chloromethylated followed 
by further functionalization steps to obtain phenol derivatives. 
In the present work, we report on a simpler technique for preparing polymeric 
microbeads. This technique has the advantages of ease of mass production and scale 
up, and the stability for repeated usage. Poly (4-vinyl pyridine)/poly (vinylidene 
fluoride) (P4VP)/(PVDF) beads prepared by the phase inversion technique were used 
as the substrate. PVDF was used to provide the mechanical strength of the beads. N-
alkylation of the P4VP was carried out with alkyl chains of different lengths since the 
length of the carbon side chains has been shown to affect the antibacterial efficacy of 
pyridinium-type polymers (Tiller et al. 2001; Tiller et al. 2002). Unlike our previous 
work, in the present work the antimicrobial efficacy against both fungal spores and 
bacteria was investigated. The microorganisms chosen for the present work were 
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Escherichia coli (E. coli) and Aspergillus niger (A. niger). E. coli has been used in a 
number of antibacterial works and this choice would make it easier for us to compare 
the efficacy of our technique (Nonaka et al. 1996; Cen et al. 2003; Kenawy and 
Mahmoud 2003; Chen et al. 2004a). A. niger was selected because of its ubiquity in 
air and its high resistance to the usual means of disinfection (such as heat, light, and 
chemical methods) (Arnoson 1965). To obtain a better understanding of the difference 
in efficacy against these two microbial species, the effect of surface pyridinium 
groups on cellular components was studied. Since antimicrobial microbeads have 
good potential for practical applications, the issue of re-usability of these beads was 
addressed using repeated batches of antibacterial and antifungal assays. 
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3.2 Materials and Methods 
3.2.1 Materials 
PVDF (Kynar, K-761) powder with molecular weight of 441,000 was obtained from 
Elf Atochem. P4VP with molecular weight of about 50,000 was obtained from 
Polysciences Inc. N-methyl-2-pyrrolidone (NMP) (reagent grade) was obtained from 
Merck. Sodium dodecyl sulfate (SDS), 1-bromobutane, 1-bromohexane, 1-
bromodecane and cetyltrimethylammonium chloride were from Aldrich. Fluorescein 
(Na salt) was obtained from Sigma Chemical Co. Peptone, yeast extract, agar and beef 
extract were obtained from Oxoid. E. coli (ATCC 14948) and A. niger (ATCC 6275) 
were obtained from American Type Culture Collection. 
3.2.2 Preparation of Microbeads 
The P4VP/PVDF microbeads were prepared by the phase inversion technique. The 
P4VP and PVDF with a specific molar feed ratio of [4VP]/[–CH2CF2–] were first 
dissolved in 20 ml NMP with a total polymer concentration of 15 wt%. The mixture 
was sprayed into a stirred 0.1 wt% SDS solution using a commercial chromatography 
sprayer. The air flow rate was kept at 4 l/min in all experiments. The microbeads were 
then washed with doubly distilled water for 48h with the water changed every 8h to 
ensure complete removal of SDS and NMP. The microbeads were then dried under 
reduced pressure. 
3.2.3 Quaternization of the P4VP 





















3 g of beads were placed in 15 ml 1-bromohexane and the reaction mixture was stirred 
for 24 h at 70oC. At the end of the reaction period, the beads were thoroughly rinsed 
with doubly distilled water for 48h with the water changed every 8 h, and the beads 
were then dried under reduced pressure. The complete removal of unreacted 1-
bromohexane from the bead surface was confirmed by the absence of covalent 
bromide (~ 70 eV) in the X-ray Photoelectron Spectroscopy (XPS) Br 3d core level 
spectrum. Alkylation of the P4VP moieties in the beads with 1-bromobutane and 1-
bromodecane was also carried out in the same manner. The N-alkylated beads with 
different carbon chain lengths were denoted as C4-beads, C6-beads and C10-beads 
according to the alkyl halides used. 
3.2.4 Bulk and Surface Analysis 
The bulk chemical composition of the microbeads was analyzed using a Perkin-Elmer 
model 2400 CHN elemental analyzer. The surface composition of the beads was 
measured using XPS on an AXIS HSi spectrometer (Kratos Analytical Ltd.) using a 
monochromatized Al K X-ray source (1486.6 eV photons) at a constant dwell time 
of 100 ms and a pass energy of 40 eV. The anode voltage was 15 kV and the anode 
current was 10 mA. The pressure in the analysis chamber was maintained at 6.710-6 
Pa or lower during each measurement. The beads were mounted on standard sample 
studs by means of double-sided adhesive tape. The core-level signals were obtained at 
a photoelectron take-off angle of 90o (with respect to the sample surface). To 
compensate for surface charging effect, all core-level spectra were referenced to the C 
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1s hydrocarbon peak at 284.6 eV. In spectral deconvolution, the linewidth (full width 
at half-maximum) of the Gaussian peaks was maintained constant for all components 
in a particular spectrum. The peak area ratios for the various elements were corrected 
using experimentally determined instrumental sensitivity factors (Moulder et al. 
1992).  
The amount of N+ on the surface of the beads was determined by the modified dye 
interaction method (Tiller et al. 2001; Lin et al. 2002a). The N-alkylated P4VP/PVDF 
beads were immersed in a 1 wt% fluorescein (Na salt) solution in distilled water for 5 
minutes with constant shaking, followed by rinsing with doubly distilled water. The 
stained beads were then placed in an aqueous solution of 0.25 wt% 
cetyltrimethylammonium chloride and the mixture was shaken for 10 minutes to 
desorb the dye. A 0.1 M aqueous phosphate buffer, pH 8.0, was then added in a ratio 
of 1 part buffer to 9 parts of cetyltrimethylammonium chloride solution and the 
absorbance of the resultant solution was measured at 501 nm using a Shimadzu UV-
1601 PC scanning spectrophotometer. The amount of dye bound to pyridinium groups 
on the bead surface was calculated on the basis of a standard calibration. The 
corresponding pyridinium concentration was then calculated based on the assumption 
of one dye molecule per seven N+ units (Tiller et al. 2002). 
3.2.5 Antibacterial Assay on E. coli 
Antibacterial efficiency tests were conducted using aqueous suspensions of E. coli. E. 
coli was cultivated in 50 ml of a 3.1% yeast-dextrose broth (containing 10 g/l peptone, 
8 g/l beef extract, 5 g/l sodium chloride, 5 g/l glucose and 3 g/l yeast extract at a pH of 
6.8) (Cunliffe et al. 1999) at 37oC. The bacterial cell concentration was estimated 
from the optical density at 540 nm, whereby the cell number was calculated based on 
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the standard calibration with the assumption that an optical density of 1.0 at 540 nm is 
equivalent to approximately 109 cells per ml (Hogt et al. 1986). The following 
antibacterial and antifungal assays were described for the C6-beads. Different 
amounts of C4-beads and C10-beads were used due to the different extents of N-
alkylation, as described in a later section. 
(a) Batch Treatment: E. coli-containing broth was first centrifuged at 2700 rpm for 
10 minutes, and after the removal of the supernatant, the cells were washed twice with 
sterilized PBS (pH 7.0) and resuspended in PBS at a concentration of 105 colony 
forming units (CFU)/ml. 50 ml of E. coli-containing PBS was mixed with different 
amounts (10 mg, 50 mg and 400 mg) of N-alkylated beads and agitated in sterile 
Erlenmeyer flasks with a GFL shaker at 150 rpm and 37°C. The beads were pre-
soaked in PBS (pH = 7.0) for 1 h before immersion in the E. coli-containing PBS to 
ensure that they were thoroughly wetted prior to contact with the E. coli. A control 
experiment was carried out using 50 mg of pristine beads under the same conditions. 
After the beads have been in contact with the bacteria suspension for a prescribed 
time, 0.1 ml of the bacteria suspension was pipetted out from the flask and 0.9 ml of 
sterile water was added to this suspension. The suspension was diluted several times, 
and 0.1 ml of the diluted suspension was spread on an agar plate made of solid growth 
agar (1.5% agar in the yeast-dextrose broth, autoclaved, poured into a Petri dish, and 
dried under reduced pressure at room temperature overnight). The plates were then 
sealed and incubated at 37°C for 24 h, and the numbers of viable cells were calculated 
from the colonies formed on the plate (Nonaka et al. 1996; Chen et al. 2004a). 
The beads after the antibacterial tests were examined using scanning electron 
microscopy (SEM) (JEOL JSM 5600LV). The beads were first washed with PBS 
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immediately after the assay and 3 vol.% glutaraldehyde in PBS was added for 5 h and 
stored at 4 oC. The glutaraldehyde solution was then removed and the beads were 
washed with PBS. The beads were then dried and sputter-coated with a thin film of 
platinum for imaging purposes. 
Antibacterial efficacy in repeated applications was investigated with 50 mg of C6-
beads. After one batch, the beads were recovered using a sintered filter of pore size of 
16 µm. The beads were then shaken in doubly distilled water for 10 minutes and used 
for the next batch of assay. 
(b) Monitoring of Loss of Cell Constituents: E. coli was cultured in 50 ml of yeast-
dextrose broth at 37°C for 24 h as described above. The E. coli-containing broth was 
centrifuged at 2700 rpm for 10 minutes and after removal of the supernatant, the cells 
were washed twice with deionized water and resuspended with deionized water at a 
concentration of 5×108 CFU/ml. 50 ml of the E. coli suspension was mixed with 400 
mg of beads bearing quaternized pyridinium groups and agitated in a sterile 
Erlenmeyer flask with a GFL shaker at 150 rpm and 37°C. After the beads have been 
in contact with the bacteria suspension for a prescribed time, 1 ml of the bacteria 
suspension was pipetted out from the flask. The samples were then immediately 
filtered with 0.2 µm syringe filters to remove the bacteria. Any DNA and RNA which 
leached from the bacteria into the supernatant was detected from the absorbance at 
260 nm. 
3.2.6 Antifungal Assay on A. niger 
A. niger was grown on potato dextrose agar for 2 weeks. Spores were rubbed from the 
agar surface with a glass rod after adding a small volume of sterile deionized water. 
The spore suspension was then filtered through glass wool to remove mycelial 
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fragments. The spore concentration was determined under a microscope using a 
haemocytometer. 
(a) Batch Treatment: A. niger was added to 50 ml of sucrose medium (containing 
100 g/l sucrose, 0.025 g/l potassium chloride, 0.5 g/l potassium hydrogen phosphate, 
0.025 g/l magnesium sulfate heptahydrate, 1.5 g/l sodium nitrate and 1.6 g/l yeast 
extract) in an Erlenmeyer flask at a final concentration of 105 spores per ml, and 
mixed with varying amounts of polymeric beads which had been pre-soaked in the 
sucrose medium for 1 h. The flask and its content was maintained at 30oC and after 
shaking at 120 rpm for 48 h, the beads were filtered and the weight of biomass in each 
flask was then measured by weighing the fungal mycelium in each Erlenmeyer flask 
after washing three times with deionized water and drying in an oven for 2 days at 
80oC. The results were then normalized with that obtained in the control experiment 
in which A. niger was exposed to the same conditions in the absence of beads. The 
SEM examination of the beads after antifungal assays was carried out in the same 
manner as that described earlier. 
The recovery of the beads was carried out in a similar manner as that described for the 
antibacterial tests on E. coli. Re-usability of the beads was evaluated by repeated 
batch treatments of the recovered beads. Four batches were carried out using the same 
beads and the results were expressed as the relative activity compared with that 
obtained from the first batch. 
(b) Potassium Leakage: Spores of A. niger were suspended in 50 ml of deionized 
water in an Erlenmeyer flask at a concentration of 105 spores per ml in the presence of 
a predetermined amount of beads. The flask was then shaken at 120 rpm at 30oC. 
Aliquots of 1 ml were removed at different time intervals and filtered using 0.2 µm 
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syringe filters to remove the cells. The filtrates were analysed for K+ content using 
inductively coupled plasma-mass spectroscopy (ICP-MS, Perkin-Elmer Elan 6100). 
The K+ content of the spore suspension without the addition of beads was also 
monitored as the control experiment. 
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3.3 Results and Discussion 
3.3.1 Properties of Microbeads 
An optical micrograph of the P4VP/PVDF microbeads prepared using the phase 
inversion technique is shown in Figure 3.1. The beads are approximately spherical 
with an average diameter of 480 50μm as measured from 50 beads using the Leica 
IM50 image manager software available with the optical microscope. The bulk 
[N]/[C] ratios of the beads prepared with different feed (4VP/–CH2CF2–) ratios, as 
determined from elemental analysis, are shown in Table 3.1. These experimental 
values compare well with the theoretical values calculated from the P4VP and PVDF 
components in the feed mixture. 
 
Figure 3.1 Optical micrograph of P4VP/PVDF microbeads prepared using a 
4VP/–CH2CF2– molar feed ratio of 0.3 
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Table 3.1 Composition of P4VP/PVDF beads before and after quaternization of pyridine groups using 1-bromohexane 
 
* As determined by elemental analysis. 
** As determined by XPS. 
*** As determined by fluorescein staining 
 
[N]/[C] ratio 
calculated  Bulk [N]/[C] ratio
* Surface [N]/[C] ratio** 4VP/-CH2CF2-mole 
ratio in feed 












0.1 0.037 0.037 0.036 0.036 0.028 0.023 109 
0.2 0.059 0.057 0.055 0.063 0.044 0.035 174 
0.3 0.073 0.070 0.068 0.078 0.056 0.043 245 
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The XPS C 1s and N 1s core level spectra of the pristine microbeads prepared using a 
4VP/–CH2CF2– ratio of 0.3 are shown in Figure 3.2a and Figure 3.2b. The C 1s core-
level spectrum can be fitted with four component peaks. The predominant peak at the 
binding energy (BE) of 284.6 eV is attributed to C-C and C-H groups in the pyridine 
ring and vinyl group. The peak at 285.5 eV is attributed to C-N bond of the pyridine 
ring (Cen et al. 2003). The ratio of the area of the two peaks is 5.03:1 which is in good 
agreement with the chemical structure of P4VP. The peaks at 285.8 eV and 290.5 eV 
are attributed to the CH2 and CF2 in PVDF (Ying et al. 2002). The area ratio of the 
two peaks is 1:1 which is in good agreement with the chemical structure of PVDF. 
The N 1s core-level spectrum of the pristine P4VP/PVDF bead (Figure 3.2b) indicates 
a predominant peak at 398.5 eV attributed to the imine moiety (=N–) in the pyridine 
group. The surface [N]/[C] ratios calculated from the area ratios from the XPS 
analysis (after correcting with the sensitivity factors) are compared to the bulk ratios 
in Table 3.1. For the beads prepared with a low (4VP/–CH2CF2–) feed ratio, the two 
ratios are in good agreement. However, as the P4VP component in the feed increases, 
the surface [N]/[C] ratio becomes higher than the value in the bulk. This is attributed 
to the surface enrichment of the more hydrophilic component (P4VP) during the 
phase inversion process. After alkylation with 1-bromohexane, a decrease in the area 
of the two peak components at 285.8 eV and 290.5 eV in the C 1s core level spectrum 
can be seen (Figure 3.2c). This decrease is attributed to the contribution of 5 carbon 
atoms per N-hexyl chain to the peak at 284.6 eV and another carbon atom to the peak 
at 285.5 eV. The N 1s core-level spectrum after 1-bromohexane derivatization (Figure 
3.2d) shows an additional peak at a binding energy above 400 eV, attributable to the 
positively charged nitrogen (Tan et al. 1990). The degree of N-alkylation of the 
pyridine groups, calculated from the [N+]/[N] ratio, for the beads prepared using a 
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4VP/–CH2CF2– feed ratio of 0.3 is 76%, which is higher than that obtained in our 
previous work (35%) (Cen et al. 2003). This increase in degree of N-alkylation is due 
to the use of neat 1-bromohexane in the present work instead of the 20 vol % 1-
bromohexane in nitromethane used in previous work. 
 
Binding Energy (eV) 
Figure 3.2 XPS C 1s and N 1s core-level spectra of microbeads (a, b) before 
N-alkylation, (c, d) after N-alkylation using 1-bromohexane and (e, 
f) after 4th batch of antibacterial tests using C6-beads. 
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In an earlier work, we have shown that the concentration of quaternary ammonium 
groups on the surface has a very significant effect on the antibacterial efficacy (Cen et 
al. 2003). The surface concentrations of the quaternary ammonium groups of the C6-
beads as estimated from N+/C area ratio are shown in Table 3.1. As expected, with a 
higher ratio of 4VP/–CH2CF2– in the feed mixture, the concentration of pyridinium 
groups is correspondingly higher. The quantitative amounts of [N+] present on the 
bead surfaces as obtained from the titration method using fluorescein (Na salt) are 
also shown in Table 3.1. This dye was reported to  bind to quaternary amino groups 
only and not tertiary or primary ones (Ledbetter and Bowen 1969). Our control 
experiments with beads with various ratios of 4VP/–CH2CF2– but not derivatized also 
confirmed that the dye only binds to quaternary amino groups. It should be noted the 
values of the N+ concentration in Table 3.1 may be over-estimated since the roughness 
of the bead surface gives rise to a higher surface area for functionalization than that 
calculated from the diameter of the bead.  
The N-alkylation with 1-bromobutane and 1-bromodecane was carried out in a similar 
manner as that described for 1-bromohexane. The degree of N-alkylation was found to 
decrease with the increase in the alkyl chain length, as shown in Table 3.2. Since the 
concentration of surface quaternary ammonia groups is expected to affect the 
antimicrobial efficacy, different amounts of beads were used to maintain a constant 







Table 3.2 Comparison of surface composition, antibacterial and antifungal 
properties of P4VP/PVDF beads N-alkylated with different alkyl bromides 
E. coli2  
260 nm absorbance 
A. niger3 
K+ concentration (ppb) 





N-alkylation After 30 min After 3h After 20 min After 4h 
01 0 0.05 0.06 820 840 
4 0.85 0.33 0.53 930 998 
6 0.76 0.32 0.56 938 1050 
10 0.36 0.29 0.60 977 1139 
1 Not alkylated. 
2 Absorbance at 260 nm after 30 min and 3 h in contact with N-alkylated beads (350 
mg C4-beads, 400 mg C6-beads and 855 mg C10-beads) in 50 ml of 5×108 
CFU/ml E. coli suspension. Different amounts of beads were used to maintain 
consistency in the total amount of N+. 
3 K+ concentration in medium after 20 min and 4 h in contact with N-alkylated 
beads (350 mg C4-beads, 400 mg C6-beads and 855 mg C10-beads) in 50 ml of 
deionized water containing 105 A. niger spores/ml.  
 
3.3.2 Antibacterial Characteristics of Beads 
The beads prepared with a 4VP/–CH2CF2– feed ratio of 0.3, which have the highest 
surface density of N+, were selected for the antibacterial and antifungal experiments. 
Figure 3.3 shows the number of viable cells after a predetermined time in contact with 
the various amounts of beads. It can be seen that more than 99.9% E. coli was killed 
after being in contact with 50 mg of C6-beads in 40 minutes, while there is only a 
slight decrease (about 6%) after contact with the same amount of pristine beads. 
When 400mg of C6-beads were used, no colony forming unit can be found after 20 
minutes. The bacteria killing rate is determined by the opportunity for collision 
between viable cells and the antibacterial sites on the beads’ surface. With a higher 
bacterial concentration and a higher amount of C6-beads, a higher bacteria killing rate 
can be expected. This is confirmed by the data in Figure 3.3, which shows that the 
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amount of C6-beads used is a critical factor in determining the survival rate of the 
bacteria, and the the number of bacteria killed per unit time decreased with the 
decrease in the bacteria concentration decreases with time as the bacteria 
concentration decreases. The results in Figure 3.3 were obtained with PBS as the 
medium. Antibacterial assays carried out with deionized water gave very similar 
results. 




























Figure 3.3 Antibacterial efficacy of different amounts of C6-beads in contact 
with 50 ml of E. coli suspension (105 CFU/ml). The control 
experiment was conducted with 50 mg of pristine beads. 
 
Since it is very important to address the issue of whether leakage of the active groups 
from the beads occurred in the bacterial suspension, an additional experiment was 
carried as follows: 50 mg of the C6-beads were shaken in 50 ml of PBS (pH 7.0) for 

















achieve a final concentration of 105 CFU/ml. After constant shaking for 40 minutes, 
the concentration of viable cells was measured. The result showed that the E. coli 
concentration decreased by 8% whereas the control experiment with 50 mg of pristine 
beads as mentioned above showed a 6% decrease in E. coli concentration in the same 
time period. Compared to the high killing rate shown in Figure 3.3, this minor 
difference can be considered negligible. The difference in results obtained from the 
pristine beads and the C6-beads (which were removed before E.coli addition) was 
analyzed statistically using the two sample t-test. This observed difference was 
considered not significant since P = 0.146. P4VP N-alkylated with 5 or more carbon 
atoms was also reported to be insoluble in water (Gargallo et al. 2001), thus, the 
amount of leaching from the beads can be expected to be very small.  
The reduction of viable cells in the suspension can be due to two factors. Firstly, the 
bacterial cells are killed or inactivated by the pyridinium groups on the bead surface. 
Secondly, the bacterial cells can adsorb or adhere onto the bead surface and be 
removed from the suspension. To investigate the second issue, the surfaces of the 
pristine and C6-beads after the antibacterial assay were examined using SEM. The 
SEM images of these surfaces show that few cells adhere on either surface. Thus, the 
reduction of viable cells in the suspension with C6-beads as shown in Figure 3.3 
cannot be due to the increased adsorption or adherence onto the C6-beads surface. 
The effect of C6-beads in killing the bacteria on contact was further studied by 
monitoring the leakage of the intracellular constituents into the suspension. 
The possible leakage of the components from lysed cells was evaluated by measuring 
the absorbance of the supernatant after the bacteria have been in contact with the N-
alkylated beads for a prescribed time. DNA and RNA have been described as “260nm 
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absorbing materials” for their strong UV absorption at 260nm (Chen and Cooper 
2002). The inset of Figure 3.4 shows the absorption spectrum of the supernatant after  
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Figure 3.4 Change in absorbance at 260 nm and viable cell number with time 
in contact with 400 mg of C6-beads in 50 ml of 5×108 CFU/ml 
bacteria suspension. Inset shows the UV-visible absorption 
spectrum of the supernatant after E. coli has been in contact with 
the beads for 1h. 
the E. coli has been in contact with the C6-beads for 1 h. Figure 3.4 shows the change 
in the absorbance of the supernatant at 260 nm and the viable cell number with time in 
contact with the C6-beads. It should mentioned that in these experiments, a much 
higher E. coli concentration was used (5×108 CFU/ml) compared to that used for the 
experiments shown in Figure 3.3 (105 CFU/ml). Nevertheless, the results in Figure 3.4 
show that 400 mg of the C6-beads can still eliminate almost all the bacteria, although 

















well with the decrease in viable cell number. In the control experiment with the same 
amount of pristine beads, the UV absorbance at 260nm remained at about 0.05-0.06 
for the three hours test period. Since it is not possible for biomacromolecules such as 
DNA and RNA to be transported through an integral cell membrane, Figure 3.4 shows 
that the cell membrane must have been disrupted upon contact with the N-alkylated 
beads. Irregular cell shape and cell membrane disruption were also reported after the 
bacteria was treated with a copolymer with quaternary ammonium and phosphonium 
groups (Kenawy and Mahmoud 2003). The interactions between biocides and cell 
membrane have been proposed as follows (Denyer 1990): (a) biocides insert the 
positively charged groups such as quaternary ammonium and phosphonium into 
phospholipids bilayer of the cell membrane and attract negatively-charged 
phospholipids; (b) phospholipid bilayers are then redistributed through interaction 
with the biocides possessing multiple positively-charged centers; (c) displacement of 
phospholipids and disorganization of membrane architecture occurs. The release of 
DNA and RNA as shown in Figure 3.4 confirms the disruption of E. coli membrane 
by the hexyl-P4VP groups at the bead surface.  
The efficacy of the alkyl chains of different lengths in disrupting the bacterial cell 
membrane can be compared by comparing the change in the 260nm absorbance. This 
comparison is shown in Table 3.2. All three types of beads are highly effective 
although the C10-beads appear to be slower in effecting the lysis of the cells. In the 
study by Nakagawa et al, they discovered that glass beads immobilized with 
quaternary ammonium salts with C2 and C4 alkyl chains showed lower activity 
against E. coli, while those with C8-C18 showed higher antibacterial activities. The 
highest potency was achieved for C10 (Nakagawa et al. 1984). Similar results were 
also reported by Chen et al., using a series of dendritic biocides. They found that the 
Chapter 3 
59 
C10 chain was the most effective, followed by C8 and C14 (Chen et al. 2000). 
However, in addition to the effect of the length of the hydrophobic chain attached to 
the quaternary ammonium groups, the surface charge density can also play an 
important role in determining the antimicrobial properties of polycationic biocides, 
since in a cell suspension, the protein on the cell wall may dissociate into positively 
charged amino groups ( 3NH
 ) and negatively charged carboxyl groups ( COO ). 
The bacteria will be charged if the pH value in the medium is not equal to the 
isoelectric point of the bacteria. E. coli is negatively charged under neutral 
environment as its isoelectric point is pH 4–5 (Li and Shen 2000). Therefore, the 
surface charged density of the biocides also affects the rate of bacteria adsorption onto 
biocide surfaces through electrostatic interaction. The hydrophilic-lipophilic balance 
and surface charged density may explain the results in Table 3.2. C4-beads with the 
highest surface charge density may be more effective in killing E. coli during short 
contact time due to the faster adsorption rate onto the beads surface. On the other 
hand, the C10-beads have lower surface charge density, but since the C10 alkyl chain 
is more effective in disrupting the cell membrane, its overall efficacy is quite similar 
to the C4-beads. However, due to the low degree of N-alkylation of the C-10 beads, 
these beads may not be as useful in practical applications since more beads would be 
required. 
It should also be mentioned that the killing potency depends on both the chemistry of 
the biocides as well as the structure of the microorganism. With S. aureus, Tiller et al. 
found that pyridine groups N-alkylated with C6 showed the highest killing efficacy 
followed by those with C3 and C4 chains and the C8-C16 chains are significantly less 
effectively (Tiller et al. 2001). However, it is not clear whether the concentrations of 
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surface pyridinium groups on the substrates were the same when different alkyl 
bromides were used for N-alkylation.  
One of the objectives of this work is to develop the functionalized beads for repeated 
applications without loss of efficacy. The results of the antibacterial efficacy in 
repeated applications of C6-beads are shown in Figure 3.5. In the 1st batch, 99.96% E. 
coli was killed after 40 minutes in contact with 50 mg of C6-beads. In comparison, in 
the 4th batch using the same beads, 99.82% E. coli was killed after the same contact 
time. The similarity in the efficacy (two sample t-test P = 0.084) shows that the C6-
beads are stable. This inference was further confirmed with the results from XPS 
analysis. The XPS C 1s and N 1s core level spectra of the beads after the 4th batch are 
shown in Figure 3.2e and Figure 3.2f. The N/C and N+/N ratios are 0.054 and 0.72 
respectively, which are only slightly different from the corresponding values (0.056 




























Figure 3.5 Repeated batches of antibacterial assays using the same 50 mg of 

















and 0.76) before the 1st batch of antibacterial assay. The reproducibility of the results 
also confirms that leaching of the active groups is not a problem, and dead cells and 
their constituents do not adversely affect the surface pyridinium groups. 
3.3.3 Antifungal Characteristics of Beads 
The antifungal assay was carried out in a different manner as the antibacterial assay 
since instead of cell division, hyphae will germinate from the A. niger spores and 
further form a filamentous mycelium. Hence, the weight of the biomass after culturing 
the spores for 2 days with and without the addition of beads was measured instead and 
the results obtained were compared. Figure 3.6 shows the effect of different amounts 
of C6-beads on the growth of A. niger cultured in a 50 ml suspension at a 
concentration of 105 spores/ml. In this Figure, the weight of biomass has been 
normalized by that obtained in the absence of beads. As can be seen from Figure 3.6, 
the result obtained from the culture with 50 mg of pristine beads is very similar to that 
obtained without any beads. In the presence of 50 mg of C6-beads, the reduction in 
the weight of biomass is only about 23%. In comparison, from the antibacterial assay 
n the previous section, 50 mg of C6-beads was shown to be effective in killing > 
99.9% of E. coli suspended in 50 ml of PBS at an initial concentration of 105 cells/ml 
within 40 minutes. Hence, in order to further increase the antifungal efficiency, the 
amount of C6-beads added to the culture medium has to be increased. A significant 
reduction in biomass can only be achieved when 300 mg of C6-beads were used and 
in this case the biomass was reduced by 67% (Figure 3.6). A further increase to 400 
mg of C6-beads resulted in complete inhibition of the fungi growth. The SEM 
micrograph of the beads after this test (Figure 3.7) shows only sporadically distributed 
spores which were either lysed or disrupted. The healthy spores are shown as a 

























































Figure 3.6 Weight of biomass from A. niger culture (50 ml of sucrose medium 
containing 105 A. niger spores/ml) in contact with different 
amounts of beads after 48 h (control – without the addition of any 
beads; 50 mg (pris) – 50 mg pristine beads were added; 50 mg 
(C6), 100 mg (C6), 200 mg (C6), 300 mg (C6) and 400 mg (C6) – 
with addition of stated amount of C6-beads). 
 
A comparison of the antibacterial and antifungal assays shows that the inhibitory 
effect of the pyridinium groups on the growth of spores of A. niger is not as effective 
as for E. coli. It is known that fungal spores have very tough spore coats and more 
components (glucans, mannans, chitin et al.) are present in the cell wall of fungi 
compared with that of bacteria (mainly peptidoglycan), which may increase the 
difficulty for the pyridinium groups to penetrate into the cell body (Weber and Hess 
1975). The present results showing the greater resistance of A. niger to the 
antimicrobial pyridinium groups as compared to E. coli is consistent with earlier 
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works (Huang et al.; Wolfrum et al. 2002) which showed that A. niger spores were 
removed much more slowly than E. coli cells on TiO2 coated-surfaces and in aqueous 
TiO2 suspension under photocatalytic conditions.  
 
Figure 3.7 Scanning electron micrograph of fungal spore on surface of C6-
bead after antifungal assay (400 mg of beads in contact with 50 ml 
of sucrose medium containing 105 A. niger spores/ml for 48 h). 
Inset shows the healthy spores before the antifungal assay. 
 
To further investigate the stability and the reusability of C6-beads, repeated batch 
treatments were carried out using 400 mg of the same beads. The results after four 
batch treatments are shown in Figure 3.8. In this Figure, a 100% antifungal efficiency 
implies complete inhibition. In the first and second batches, complete inhibition was 
obtained. However, in the third and fourth batches, the efficiency has decreased to 
60%. Since it has been already established in an earlier section that the beads are 
stable and leaching of the pyridinium groups is unlikely, the decrease in killing 






























Figure 3.8 Repeated antifungal assays with the same 400 mg of C6-beads in 
contact with 50 ml of sucrose medium containing 105 A. niger 
spores/ml for 48 h. 
surface may have become inaccessible due to coverage by the components in the 
culture medium or by residues of the lysed A. niger spores. The medium for the 
antifungal assay is different for that used for the antibacterial assay since nutrients are 
needed for the fungal spores to germinate and grow. PBS used for the antibacterial 
assay does not contain any sugar or peptides, unlike the culture medium for the A. 
niger, so the problem of the adhesion of these substances on the bead surface would 
only arise in the antifungal assay. The effect from the culture medium and the spore 
residues may be cumulative from the first batch, but may not be significant enough 
until the third batch. Since the beads were subjected to constant shaking at 120 rpm 
during each batch, it is possible that the residues on the beads surface are also in a 
dynamic process of detaching and attaching, which accounts for the similar efficiency 
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observed in the third and fourth batches. In order to understand how the medium may 
affect the surface of the beads, a similar experiment was carried out using deionized 
water as the culture medium. In this case, with no available nutrients, no hyphea can 
germinate from spores to form mycelium. To monitor the killing of the spores by the 
N-alkylated beads, the concentration of K+ in the medium was monitored since the K+ 
leakage is an ideal indicator of damage to the membranes of the microorganisms 
(Codling et al. 2003). The DNA and RNA absorbance was not used in this case since 
the absorbance is too low to be accurately measured with 105 spores/ml. 
The K+ concentration in the medium as a function of time in contact with the beads is 
shown in Figure 3.9. The culture without any beads shows a low concentration of K+  


























Figure 3.9 K+ concentration in the medium with and without 400 mg of C6-
beads in contact with 50 ml of deionized water containing 105 A. 
niger spores/ml.  
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which is slowly increasing, probably due to the osmotic balance between the K+ 
content in the cells and the extracellular environment. In the presence of 400 mg of 
C6-beads, the concentration of K+ in the medium exhibits a very significant increase 
in the first 10 minutes compared with the corresponding value obtained without beads. 
The K+ concentration increases with the time in the first two hours and levels off after 
4 h. The value after 48 h (the culture time used in the previous section for obtaining 
the weight of biomass) is close to that at 4 h, confirming that a plateau has been 
reached. This set of experiments indicates that the vast majority of A. niger spores 
have been destroyed after being in contact with the C6-beads for 4 h.  
The antifungal efficacy of the N-alkylated beads with different chain lengths (C4, C6 
and C10) was also compared as shown in Table 3.2. The C10-beads exhibited the 
highest killing potency among those tested. As mentioned earlier, the antibacterial and 
antifungal assays showed that the A. niger spores are more resistant to the pyridinium 
groups due to the thicker and more complex structure of the fungal spore coats. Thus, 
the C10 chains may interact more effectively with the surface components of the 
fungal spores causing more extensive disruption. Moreover, the spores are more 
hydrophobic than E. coli cells (Wolfrum et al. 2002), which may also account for the 
highest killing efficacy of the C10 chains among the different chains tested due to the 
more hydrophobic nature of such chains.  
The K+ leakage experiment was then carried out for four repeated batches using 400 
mg of C6-beads beads. The results, shown in Figure 3.10, indicate that similar values 
of the K+ concentration were obtained in all four batches. This would imply that the 
antifungal efficiency of the C6-beads was maintained throughout the four batches. 
This result would be consistent with the antibacterial efficiency in the repeated assays 
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discussed earlier. Thus, it may be concluded that the decrease in the antifungal 
efficiency of the C6-beads observed with the sucrose medium is probably due to the 
interaction between surface functional groups on the beads and the components in the 
medium. In practical applications, such as water or wastewater treatments, the 
medium may not contain rich nutrients similar to those of the sucrose medium used 
here. Hence, the applicability of repeated use of the N-alkylated beads developed in 
the current work could be envisaged. 



























Figure 3.10 K+ concentration in the medium after 4 h in each repeated batch of 
antifungal assay using the same 400 mg of C6-beads in contact 






A phase inversion technique has been successfully employed to prepare P4VP/PVDF 
microbeads. With this technique, microbeads with spherical shape and narrow particle 
distribution can be easily produced in large quantities. After quaternization of 
pyridine groups on the surface of the microbeads with alkyl bromides, the microbeads 
possess effective antibacterial and antifungal properties. The leakage of intracellular 
constituents from the bacteria cells and fungal spores upon contact with the N-
alkylated beads confirms the lysing of the cells. The pyridinium groups bearing alkyl 
substituents of four to ten carbons in length are highly effective in disrupting the cell 
membrane of the E. coli. The beads N-alkylated with C4 and C6 chains have a high 
surface concentration of pyridinium groups. As such an amount of beads of ~0.8 wt% 
of an E. coli suspension of 105 CFU/ml can result in almost 100% killing efficiency 
within 20 minutes. A larger amount of beads is required to achieve the same killing 
rate of A. niger spores due to the more resistant nature of the fungal wall. The longer 
C10 hydrophobic chain appears to be the most effective in disrupting the fungal wall. 
The functional groups on the bead surface are highly stable, and effective 









CHAPTER 4 SYNTHESIS AND IN VITRO ANTI-
TUMORAL EVALUATION OF TAMOXIFEN-






The last Chapter describes the preparation and surface functionalization of polymeric 
microbeads for antibacterial and antifungal applications. Besides the bacteria and 
fungi, another significant medical threat to human beings is malignant cells. Cancer 
was once considered an incurable disease. Although today patients diagnosed with 
early stage disease could survive their illness due to the improvement in cancer 
diagnostics and therapeutics over the last few decades, cancer is still the second 
leading cause of death (Heron 2007). Efficient cancer chemotherapy requires a high 
degree of selective localization of cytotoxic drugs in the tumor. It has been suggested 
that particles smaller than 1 µm can undergo capillary distribution and uniform 
perfusion at the desired target site (Arias et al. 2001). Thus for diagnosing and 
eliminating cancer cells, functionalized nanoparticles would be more suitable than 
micro-sized particles. The next part of my thesis described the synthesis and 
functionalization of different types of nanoparticles for diagnosing and eliminating 
cancer cells. 
Tamoxifen is the most widely used drug for the treatment of estrogen receptor-
positive breast cancer and is the only drug approved for the prevention of breast 
cancer in healthy women at high-risk of breast cancer (Bonneterre et al. 2000; 
O'Regan and Jordan 2002). It acts as an anti-estrogen by binding to the estrogen 
receptor. The tamoxifen-estrogen receptor complex binds with DNA and can alter or 
block subsequent mRNA transcription leading to cellular apoptosis (Cameron et al. 
1997). Promising success rates of tamoxifen in the treatment of advanced breast 
cancer have been reported (Ravdin et al. 1992; Osborne 1998). However, tamoxifen 
also has estrogenic effects in the uterus and the most significant side effect of 
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tamoxifen treatment appears to be increased risks of endometrial cancer. Other side 
effects include liver cancer, pulmonary emboli, venous thrombosis and ocular side 
effects such as retinopathy and corneal opacities (de Lima et al. 2003). 
These side effects were reported to be dose and concentration dependent (Peyrade et 
al. 1996), and an increased risk of endometrial cancer has been associated with 
duration of treatment and accumulated dose (Rutqvist et al. 1995; Clarke et al. 1998; 
Fisher et al. 1998). The activity and side effects of tamoxifen may also be attributed to 
its biologically active metabolites and their accumulation in target tissues (Kisanga et 
al. 2004). Through drug targeting, these negative side-effects can be minimized by 
maintaining the drug concentration in other non-target organs and tissues at below 
certain minimal levels. Magnetically-guided particles are regarded to have excellent 
potential as drug targeting carriers due to its non-invasive character and high targeting 
efficiency (Voltairas et al. 2002). By application of an external magnetic field, 
magnetic drug carriers could be retained to achieve very high concentrations of the 
chemotherapeutic agent near the target site for a given period of time without any 
toxic effects to normal surrounding tissue or to the whole body. 
The first clinical cancer therapy trial using magnetic targeting carriers was performed 
by Lubbe et al. for the treatment of advanced solid cancer (Lubbe et al. 1996a; Lubbe 
et al. 1996b; Lubbe et al. 2001). In contrast to systemic chemotherapy, they found a 
much higher drug concentration in the tumor and the peritumoral area by using only 
50% and 20% of the normal dose (Alexiou et al. 2003). FeRx (San Diego, CA, USA) 
also carried out Phase I/II clinical trials with its Magnetic Targeted Carrier technology 
(Rudge et al. 2000; Fricker 2001; Rudge et al. 2001). In these carriers, the 
chemotherapeutic agents were adsorbed on the surface of the carriers and quickly 
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released in 1~2 h (Rudge et al. 2001; Alexiou et al. 2003). Recently, magnetite 
nanoparticles covered with a layer of biodegradable polymer shell or evenly 
distributed in the matrix of polymer nanoparticles have been reported as potential 
drug targeting vehicles (Arias et al. 2001; Asmatulu et al. 2005; Okassa et al. 2005; 
Zheng et al. 2005; Gomez-Lopera et al. 2006). The magnetite/polymer composite 
nanoparticles have demonstrated lower in vivo toxicity than magnetite (Iannone et al. 
1991; Muller et al. 1996). 
This chapter describes the synthesis of tamoxifen-loaded magnetite/poly(L-lactic 
acid) (PLLA) composite nanoparticles (TMCN) and the evaluation of its cytotoxicity 
against MCF-7 breast cancer cells. With its superparamagnetic property, these 
nanoparticles can also be used as contrast agents for magnetic resonance image 
(MRI), with which the distribution of TMCN can be visualized in vivo (Tiefenauer et 
al. 1996; Perez et al. 2004). PLLA is a biodegradable polyester that is widely used in 
drug delivery application and the encapsulation of tamoxifen in the polymer matrix 
can extend the release profile over that achievable from the adsorption of the drug on 
the magnetic particles surface. Moreover, nanoparticulate carrier systems formulated 
with tamoxifen can increase drug concentration in tumors through enhanced 
permeability and retention (EPR) effect (Chawla and Amiji 2002; Chawla and Amiji 
2003; Cavallaro et al. 2004; Fontana et al. 2005; Memisoglu-Bilensoy et al. 2005). 
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4.2 Materials and Methods 
4.2.1 Materials 
Benzyl ether, 1, 2-hexadecanediol, oleic acid, oleylamine, iron (III) acetylacetonate 
were purchased from Aldrich Chemical Co. Poly(vinyl alcohol) (PVA) with MW of 
30,000-70,000, poly(L-lactic acid) (PLLA) with MW of 85,000-160,000, RPMI-1640 
medium, fetal bovine serum, L-glutamine, penicillin-streptomycin solution, tamoxifen 
(trans-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-N,N-dimethylethylamine), methyl-
thiazolyldiphenyl-tetrazolium bromide (MTT), phosphate buffered saline (PBS, pH 
7.4), trypsin-EDTA solution were purchased from Sigma. Dimethyl sulfoxide 
(DMSO), ethanol, hexane, dichloromethane (DCM) and methanol were purchased 
from either Fisher Scientific or Aldrich and used as received. De-ionized (DI) water 
(Millipore) was used throughout the experiment. MCF-7 breast cancer cells were 
purchased from ATCC. 
4.2.2 Preparation of Magnetic Nanoparticles 
The Fe3O4 magnetic nanoparticles were prepared according to an earlier reported 
method (Sun et al. 2004): iron(III) acetylacetonate (5 mmol), 1,2-hexadecanediol (25 
mmol), oleic acid (15 mmol), oleylamine (15 mmol), and phenyl ether (50 ml) were 
mixed and magnetically stirred under a flow of nitrogen. The mixture was heated to 
200 C for 2h and then, under a blanket of nitrogen, heated to reflux (300 C) for 
another 1 h. The black mixture was cooled to room temperature after removal of the 
heat source. Under ambient conditions, ethanol (100 ml) was added to the mixture, 
and a black material was precipitated and separated via centrifugation. The black 
product was dissolved in 40 ml of hexane in the presence of oleic acid (1 ml) and 
oleylamine (1 ml). Centrifugation (6000 rpm, 10 min) was applied to remove any 
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undispersed residue. The product, Fe3O4 nanoparticles of ~6 nm, was then precipitated 
with ethanol, centrifuged (6000 rpm, 10 min) to remove the solvent, and then dried 
under reduced pressure and stored at 0-4 C. 
4.2.3 Preparation of Tamoxifen-loaded Magnetite/PLLA Composite 
Nanoparticles (TMCN) 
Oleic acid-stabilized 6 nm Fe3O4 magnetic nanoparticles were prepared via a high 
temperature reaction of iron acetylacetonate in phenyl ether in the presence of alcohol, 
oleic acid and oleylamine according to a reported method (Sun et al. 2004). The 
particles are quite uniform and can disperse uniformly in organic solvents. The Fe3O4-
containing polymeric nanoparticles were prepared by the solvent 
evaporation/extraction technique in o/w emulsion with PLLA as the encapsulation 
material. The TMCN were prepared using the following procedure: 100 mg of PLLA, 
20 mg of 6 nm Fe3O4 and 7.5 mg of tamoxifen were dissolved in 8 ml 
dichloromethane and vortexed for 10 min to make the organic phase. The organic 
phase was then poured into 50 ml of stirred aqueous solution containing 1 % PVA as 
emulsifier. The mixture was sonicated for 120 s with an ultrasonic processor (Sonics, 
VCX 130 PB). The formed o/w emulsion was then stirred at room temperature 
overnight with a magnetic stirrer to evaporate the organic solvent. The TMCN were 
collected by centrifugation at 10,000 rpm for 10 minutes and washed three times with 
DI water. The nanoparticles were resuspended with 10ml water and freeze-dried 
(Edwards freeze dryer, ESM 1342) for two days. The amounts of Fe3O4 and 
tamoxifen were varied to obtain different TMCN. The PLLA nanoparticles without 
and with Fe3O4 (PLAN and FeLN, respectively) were prepared in the same manner 
except that only 100 mg PLLA and 20 mg Fe3O4 were used in the organic phase for 
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preparing FeLN, and only 100 mg PLLA was used for PLAN. All experiments with 
tamoxifen were carried out under subdued light as the drug is photosensitive. 
4.2.4 Characterization of the Magnetic Carrier 
4.2.4.1 Particle Size and Surface Properties 
The size distribution of the nanoparticles were determined by dynamic light scattering 
(DLS) method using a 90 Plus particle size analyzer from Brookhaven Instruments at 
25 °C and at a 90° detection angle. The freeze-dried nanoparticles were suspended in 
DI water and sonicated for 10 min to form a uniform dispersion. The morphology of 
the nanoparticles was imaged using a field emission scanning electron microscope 
(FESEM JEOL JSM-6700F). The distribution of Fe3O4 nanoparticles in the magnetic 
carriers was observed using transmission electron microscopy (TEM, JEOL JEM-
2010F) at an accelerating voltage of 200 kV. 
The zeta potential of the nanoparticles suspended in DI water (after sonication) was 
determined using the Zeta Plus analyzer (Brookhaven Instruments). For particle size 
and surface charge measurements, the mean value of 5 readings was reported. The 
surface composition of the TMCN was determined with XPS as described in Section 
3.2.4. 
4.2.4.2 Fe3O4 Loading and Tamoxifen Encapsulation Efficiencies 
The loading of Fe3O4 nanoparticles incorporated in the magnetic carrier was 
determined by thermogravimetric analysis (TGA) carried out with a TGA 2050 
Thermogravimetric Analyzer (TA Instruments). Samples weighing between 5 to 15 
mg were heated from 30 to 700 C at a heating rate of 10 C/min in air. Measurement 
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of magnetization of the nanoparticles was carried out with a Vibrating Sample 
Magnetometer (VSM, DMS 1600). 
The amount of tamoxifen incorporated in the nanoparticles was determined in 
triplicate by HPLC assay. A known amount of the nanoparticles (2 mg) was re-
dissolved in DCM (2 ml) and 5 ml of acetone was then added. A stream of nitrogen 
was introduced to evaporate the DCM. The solution was then made up to 5 ml with 
additional acetone to compensate for the amount evaporated. The solution was filtered 
through a 0.45-µm membrane filter before HPLC assay using a Hewlett-Packard 1100 
HPLC system. A reverse phase C18 column (Zorbax, Hewlett-Packard) was used as 
the stationary phase and 1.0% (v/v) triethylamine in DI water/methanol (11:89, v/v) 
was used as the mobile phase. The injection volume was 20 µl and the flow rate of the 
mobile phase was 0.8 ml/min. The column effluent was monitored at 265 nm with a 
UV detector. The amount of tamoxifen in the nanoparticles was determined from the 
calibration curve of the drug in acetone. The encapsulation efficiency of the drug was 
calculated as the mass ratio of the amount of the drug entrapped in nanoparticles to 
that used in the nanoparticle preparation. 
4.2.5 In vitro Tamoxifen Release Studies 
The in vitro release of the tamoxifen from the nanoparticles was carried out in PBS 
(pH 7.4) containing 0.5% (w/v) sodium lauryl sulfate (SLS). SLS was used to increase 
the solubility of tamoxifen in the buffer solution and prevent adsorption of the 
tamoxifen on the surface of the tube (Chawla and Amiji 2002). 3 mg of the freeze-
dried, drug-loaded nanoparticles were suspended in 10 ml SLS-PBS in a 15-ml 
centrifuge tube and kept in a GFL shaker at 150 rpm and 37°C. After a particular time 
interval, the tubes were taken out and centrifuged at 10000 rpm for 10 min, and then 
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5.0 ml sample of the supernatant was withdrawn. Following this, 5.0 ml of fresh SLS-
PBS was added to the test tube to maintain sink conditions. The supernatant was 
filtered through a 0.45-µm membrane filter and the concentration of the drug was 
determined by HPLC assay as described above. The cumulative amount and 
percentage of tamoxifen released from the nanoparticles were determined. 
4.2.6 Cell Culture Assay 
The MCF-7 cells were routinely cultured in RPMI-1640 medium, supplemented with 
10% fetal bovine serum, 2mM L-glutamine and 1% penicillin-streptomycin solution 
at 37 C in a humid atmosphere containing 5% CO2. 
4.2.6.1 Nanoparticle Uptake by MCF-7 Cells 
The nanoparticle uptake by MCF-7 cells was determined from the amount of ion in 
the cells. MCF-7 cells (1 ml) at a density of 5×104 cells/ml were seeded in a 24-well 
plate in the complete growth culture medium. After culturing in a 5% CO2 incubator 
for 24 h, the medium was exchanged with 1 ml medium with a specified concentration 
of FeLN or TMCN. After incubation at 37 C for prescribed time periods, the cells 
were washed with PBS three times to remove the nanoparticles in the medium, and 
detached with trypsin-EDTA solution. After counting with a hemocytometer, the cells 
were collected by centrifugation, and the cell pellet was dissolved in 37% HCl at 60 
C for 2h. The iron concentration was determined using inductively coupled plasma-
mass spectroscopy (ICP-MS, Perkin-Elmer Elan 6100). 
4.2.6.2 Inhibition of MCF-7 Cells Proliferation 
Anticancer activity of the TMCN was assayed on MCF-7 breast cancer cell by the 
MTT method (Cavallaro et al. 2004; Fontana et al. 2005). Control experiments were 
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carried out using the complete growth culture medium only (serving as non-toxic 
control). Media containing 500 µg/ml PLAN and 500 µg/ml FeLN were used as the 
cytotoxicity control. MCF-7 cells (100 µl) at a density of 5×104 cells/ml were seeded 
in a 96-well plate in the complete growth culture medium. After culturing for 12 h, the 
medium was exchanged with 100 µl medium containing a specified concentration of 
TMCN, or 500 µg/ml PLAN or 500 µg/ml FeLN. After a specified period of time, the 
culture medium from each well was removed and the cells were washed twice with 
PBS. 100 µl of the complete growth culture medium and 20 µl MTT solution (5 
mg/ml in PBS) were then added to each well. After 4 h of incubation at 37 °C and 5% 
CO2, the media were removed and the formazan crystals were solubilized with 100 µl 
DMSO for 15 min. The amount of formazan was then determined from the optical 
density at 570 nm by a microplate reader (Tecan GENios). The results were expressed 
as percentages relative to the result obtained with the non-toxic control. 
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4.3 Results and Discussion 
4.3.1 Characterization of the Magnetic Carrier 
4.3.1.1 Fe3O4 Loading and Distribution 
The as-synthesized Fe3O4 nanoparticles are quite uniform with a particle size of 
6.2±0.7 nm (Sun et al. 2004; Hu et al. 2006). Okon et al. have demonstrated that in 
the case of very small superparamagnetic (i.e. single domain) magnetite particles, 
biodegradation can occur in the lysosomes of the cells of the monocyte phagocytic 
system (MPS) giving rise to free iron, which is finally bound to transferrin and ferritin 
(Okon et al. 1994). The magnetic nanoparticles disperse well in organic solvents due 
to the presence of oleic acid on the particle surface and can be readily incorporated 
into the PLLA matrix. Figure 4.1 shows the TEM image of the TMCN. The well-
dispersed nature of the Fe3O4 nanoparticles in the PLLA matrix can be more clearly 
seen in the inset of Figure 4.1, where the Fe3O4 nanoparticles appear as white 
domains. 
A series of TMCN with different amounts of Fe3O4 nanoparticles added to the organic 
phase were prepared to study the Fe3O4 nanoparticles encapsulation efficiency 
(expressed as the percentage of magnetite in the composite nanoparticles divided by 
that used in the formulation). The TGA plot of the as-synthesized magnetic 
nanoparticles in air shows a weight loss of about 23% after heating to 700 C (Figure 
4.2a). The residue is red-brown in color, which indicates the oxidation of Fe3O4 to 
Fe2O3. The weight of organic fraction, which is mainly oleic acid, is calculated to 




Figure 4.1 TEM images of TMCN prepared with 100 mg PLLA, 20 mg Fe3O4 
and 5 mg tamoxifen. Scale bar=50 nm for the inset. 
















Temperature (oC)  
Figure 4.2 TGA curves of (a) pristine magnetic nanoparticles, (b) TMCN 
(prepared with 100 mg PLLA, 20 mg Fe3O4 and 5mg tamoxifen). 
TGA was carried out in air at a heating rate of 10 C/min. 
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of the TMCN which was prepared with 100 mg PLLA, 20 mg Fe3O4 and 5mg 
tamoxifen. The Fe2O3 residue is 10.2%, from which the Fe3O4 encapsulation 
efficiency is calculated to be 81%. The Fe3O4 nanoparticles encapsulation efficiency 
in the PLLA matrix as a function of the amount of Fe3O4 in the organic phase is given 
in Figure 4.3. All TMCN were prepared with 100 mg PLLA and 5 mg of tamoxifen. 
The figure shows that the encapsulation efficiency of Fe3O4 nanoparticles is 80~90% 
when less than 20 mg of Fe3O4 nanoparticles were used in preparing the TMCN. The 
encapsulation efficiency decreases when more than 15 mg of Fe3O4 nanoparticles 
were used, although the total amount of Fe3O4 encapsulated continues to increase. 
























Fe3O4 Nanoparticle Added (mg)
 
Figure 4.3 Magnetic nanoparticle encapsulation efficiency as a function of 
Fe3O4 concentration in the organic phase (with 100 mg PLLA and 





















Figure 4.4 Field dependent magnetization at 25 °C for (a) pristine magnetic 
nanoparticles, (b) TMCN (prepared with 100 mg PLLA, 20 mg 
Fe3O4 and 5mg tamoxifen). 
The saturation magnetization value of the pristine Fe3O4 nanoparticles is 52 emu/g at 
25 C, and neither remainance nor coercivity is observed (Figure 4.4a), which 
indicates that the as-synthesized magnetic nanoparticles are superparamagnetic. 
Superparamagnetism, (i.e. responsiveness to an applied magnetic field without 
retaining any magnetism after removal of the magnetic field), is an especially 
important property needed for magnetic targeting carriers, because capillary blockage 
by aggregations formed by residue magnetism after removal of the applied field will 
be avoided. Furthermore, these nanoparticles with superparamagnetic property have 
been used as MR T2 contrast agents. In their natural state, the magnetic moments of 
these magnetic domains are oriented randomly, but in the presence of an external 
magnetic field, magnetic moments of these domains are aligned along the field. As a 
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result, magnetic susceptibility in a system with such nanoparticles usually far exceeds 
those of paramagnetic materials, such as Gd chelates which are widely used as T1 
contrast agents (Kuperman 2000). No remainance or coercivity is also observed with 
the TMCN, which further confirms that the single-domain magnetite nanoparticles 
remain separated in the PLLA matrix. The saturation magnetization value is 7.3 
emu/g for the TMCN prepared with 100 mg PLLA, 20 mg of Fe3O4 nanoparticles and 
5 mg of tamoxifen (Figure 4.4b). 
4.3.1.2 Drug Loading and in vitro Release 
A series of TMCN formulated with different amounts of tamoxifen in the organic 
phase were prepared to study the tamoxifen encapsulation efficiency. Figure 4.5 
shows the tamoxifen encapsulation efficiency in the TMCN as a function of the 
amount of tamoxifen in the organic phase. The encapsulation efficacy of tamoxifen in 
TMCN is around 60% when less than 7.5 mg of tamoxifen was added to the PLLA 
solution in DCM containing 20 mg magnetic nanoparticles. The encapsulation 
efficacy decreases when more than 7.5 mg tamoxifen was added. With the very low 
water solubility of tamoxifen (~0.4 µg/ml) (Cavallaro et al. 2004), it is expected that 
almost all the tamoxifen would be incorporated in the PLLA polymer matrix. The 
tamoxifen which remained in solution may be the result of its increased solubility due 
to the PVA surfactant or the formation of micelles in the aqueous phase. The presence 
of tamoxifen in the PLLA matrix has no obvious effect on the Fe3O4 nanoparticle 
encapsulation efficiency. The Fe3O4 nanoparticle encapsulation efficiency is 83% for 
FeLN, which was prepared with 100 mg PLLA and 20 mg of Fe3O4 nanoparticles in 
the absence of tamoxifen, compared to the corresponding value of 81% when 5 mg 
tamoxifen was added to the same amount of PLLA and Fe3O4. 
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Figure 4.5 Tamoxifen encapsulation efficiency as a function of tamoxifen 
concentration in the organic phase (with 100 mg PLLA and 20 mg 
Fe3O4 in the organic phase). Data represent mean±SD, n=3. 
 
The in vitro tamoxifen release profile from TMCN into SLS-PBS at 37 °C is shown in 
Figure 4.6. 57% of the entrapped drug was released in the first 24 h and 88% was 
released in 6 days. The release of the drug from TMCN is very much delayed 
compared to that from poly(ε-caprolactone) (PCL) nanoparticles (prepared from 
acetone-water system), where 68% of the entrapped drug was released in first hour 
and almost all the drug was released in 24 h (Chawla and Amiji 2002). The prolonged 
delay can be explained on the basis of the differences in the distribution of tamoxifen 
within the nanoparticles prepared using different organic solvent-water systems. More 
tamoxifen (with its high solubility in organic solvent but not in water) may partition 
into the aqueous phase when an organic solvent that is more miscible with the 
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aqueous phase is used. With its low solubility in water, any drug which diffuses with 
the organic solvent into the aqueous phase will re-crystallized and deposit onto the 
hydrophobic nanoparticle surface. Hence more drug is expected to be distributed on 
the nanoparticle surface when acetone is used as the solvent instead of DCM which 
has very limited miscibility with water. 























Figure 4.6 In vitro release profile of tamoxifen from TMCN (prepared with 
100 mg PLLA, 20 mg Fe3O4 and 7.5 mg tamoxifen) in SLS-PBS at 
37 C. Data represent mean±SD, n=3. 
 
4.3.1.3 Particle Size, Morphology and Surface Properties 
Particle size is an important parameter for drug delivery carriers. It has been 
suggested that particles smaller than 1 µm can undergo capillary distribution and 
uniform perfusion at the desired target site (Arias et al. 2001). Most solid tumors have 
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elevated levels of vascular permeability. Particles less than 400 nm can cross vascular 
endothelia and accumulate at the tumor site via the enhanced permeability and 
retention effect (Nomura et al. 1998; Monsky et al. 1999; Maeda et al. 2000). The 
morphology of the TMCN is shown with FESEM image in Figure 4.7. The mean 
particle size for the three types of nanoparticles as determined by DLS was found to 
be ~200 nm with a narrow size distribution (Table 4.1). The nanoparticles appear 
spherical and well-separated. Most of the nanoparticles are ~ 250 nm and no pores 
can be observed under high magnification (100,000×). The similarity between the 
particle sizes determined from DLS and the FESEM image confirms that these 
particles disperse well in aqueous medium. 
 
Figure 4.7 FESEM images of TMCN (prepared with 100 mg PLLA, 20 mg 




Table 4.1 Particle size distribution and zeta potential 
Nanoparticles Particle size (nm) Zeta potential (mV) 
PLAN 195±22 -21.1±2.3 
FeLN 221±17 -17.7±1.6 
TMCN* 209±20 -13.4±1.3 
* prepared with 100 mg PLLA, 20 mg Fe3O4 and 7.5 mg tamoxifen. 
 
The surface charge of the nanoparticles is of interest since it influences the stability of 
the nanoparticle suspension and interactions of the nanoparticles with cell membrane. 
From zeta potential analysis (Table 4.1), the PLAN has a negative charge of -21 mV 
on the surface. This is attributed to the -COOH groups of PLLA on the particle 
surface. As the –COOH group can couple onto the Fe3O4 nanoparticle surface, the 
surface charge of the FeLN is reduced to -17.7 mV. The negative charge of the 
TMCN is further reduced to -13.4 mV due to the adsorption of tamoxifen, which is a 
weak base with a pKa of 8.85, onto the nanoparticle surface. The surface charge of 
tamoxifen-loaded nanoparticles (without Fe3O4) can vary widely from -21 to +25 mV, 
depending on the distribution of tamoxifen in the nanoparticles as well as the nature 
of the polymeric matrix (Chawla and Amiji 2002; Cavallaro et al. 2004; Maillard et 
al. 2005; Shenoy and Amiji 2005). The values obtained in the present work are within 
this range. 
From the XPS wide scan spectrum of TMCN (Figure 4.8a), two strong photoelectron 
lines are present at binding energy (BE) of about 284 and 530 eV, attributable to C 1s 
and O 1s, respectively. Two weak photoelectron lines at BE of about 400 and 710 eV 
are attributed to N 1s and Fe 2p, respectively. The peak in the high-resolution 
spectrum of N 1s (Figure 4.8c) confirms the presence of tamoxifen on the surface of 




Figure 4.8 (a) XPS wide scan, (b-d) C 1s, N 1s and Fe 2p core level spectra of 
TMCN (prepared with 100 mg PLLA, 20 mg Fe3O4 and 7.5 mg 
tamoxifen). 
 
spectrum also confirm the presence of Fe3O4 nanoparticles on the TMCN surface 
(Figure 4.8d). The C 1s spectrum of the TMCN (Figure 4.8b) was deconvoluted by 
first, accommodating the peaks of the main component, PLLA, and then fitting in the 
other contributions primarily from PVA, and tamoxifen. The C atoms in PLLA fall 
into three groups CH3, C-O and O=C-O with BE of 284.6, 286.3 and 288.7 eV, 
respectively (Figure 4.8b) (Moulder et al. 1992). As PLLA has equal numbers of C 
atoms in these three groups, the area ratio of the three peaks attributed to PLLA can 
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be set to 1:1:1, as shown in Figure 4.8b. The peak with the BE at 286.1 eV is 
attributed to C-OH from PVA (Moulder et al. 1992) and the area of this group 
accounts for 8.7% of the total area of the C 1s. From the area ratio of the respective 
peaks attributed to PVA and PLLA and the chemical formula of these compounds, the 
weight ratio of PVA to PLLA on the nanoparticle surface is then calculated to be 1:4. 
Earlier works have reported that the total amount of PVA residue on poly(D,L-
lactide) and poly (D,L-lactide-co-glycolide) nanoparticles prepared using the 
emulsion method is about 3-5% when 1% of PVA is used as emulsifier (Zambaux et 
al. 1998; Sahoo et al. 2002). The higher PVA concentration obtained in this work 
from XPS analysis indicates that PVA is concentrated on the nanoparticle surface 
since XPS is a highly surface sensitive technique (probing depth of 5-10 nm). A high 
concentration of PVA on the TMCN surface is expected to aid in the dispersion of the 
TMCN in aqueous solution. 
4.3.2 Cell Culture Assay 
4.3.2.1 Cell Uptake of TMCN 
A comparison of the cell morphology of the MCF-7 cells after 4 h incubation in 
complete culture medium and in the medium containing 500 µg/ml of TMCN is given 
in the phase contrast microscopy images in Figure 4.9. The MCF-7 cells incubated in 
complete culture medium (Figure 4.9a) were well-separated, and they spread and 
attach to the walls of the vessel, indicating viability of the cells. On the other hand the 
MCF-7 cells incubated in TMCN medium have become more rounded with cell 
aggregation and less spreading (Figure 4.9b). Black spots are also present in these 
cells (as indicated by arrows in Figure 4.9b), which are likely to be the TMCN taken 
in. The cells in Figure 4.9b also show the presence of vesicles. The significant 
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changes in the cell morphology after incubation with the TMCN provide evidence that 
the tamoxifen in the TMCN has retained its activity and is effectively released to the 
cells. The cytotoxicity activity is discussed in detail in the next section. 
 
Figure 4.9 Phase contrast microscopic images of MCF-7 cells (a) in control 
culture, (b) after 4 h of growth in media containing 500 µg/ml of 
TMCN (containing 12.4% Fe3O4 nanoparticles and 3.5% of 





It has been reported that cellular uptake of the nanoparticles is primarily mediated by 
nonspecific endocytotic process (Chawla and Amiji 2003) and 1 h after the 
administration of the tamoxifen-loaded PCL nanoparticles to MCF-7 cells the 
intracellular tamoxifen concentration reached a plateau (Chawla and Amiji 2003). 
Figure 4.10 shows that with increasing nanoparticle concentration in the incubation 
medium, the intracellular iron concentration also increases. The MCF-7 cells 
incubated with FeLN (i.e. no tamoxifen) generally have a slightly higher intracellular 
iron concentration than those incubated with TMCN. This can be attributed to the fact 
that when equal weights of the FeLN and TMCN are used, there will be higher Fe3O4 
content in the former. Based on the intracellular iron concentrations, the amount of 
TMCN and tamoxifen internalized by the cells can be calculated. As the TMCN used 
in these cell uptake experiments contains 12.4% Fe3O4 nanoparticles and 3.5% of 
tamoxifen, the amount of TMCN internalized into the MCF-7 cells after 4 h 
incubation with 50 µg/ml TMCN is 45 pg/cell and the corresponding amount of 
tamoxifen internalized by the cells is 1.6 pg/cell. When the TMCN concentration in 
the medium is increased to 500 µg/ml, the amount of TMCN and tamoxifen 
encapsulated in these nanoparticles increased to 182 pg/cell and 6.7 pg/cell, 
respectively. In the computation of these numbers, the amount of tamoxifen released 
into the medium has been neglected. From Figure 4.6, we estimate that about <27% of 
the tamoxifen would have been released. The calculated range of tamoxifen 
internalized by the cells is comparable with the values experimentally determined in 




























Figure 4.10 Effect of FeLN and TMCN concentration in the culture medium 
on iron concentration in MCF-7 cells after 4 h incubation at 37 °C. 
Data represent mean±SD, n=3. The FeLN and TMCN were 
prepared with 100 mg PLLA and 20 mg Fe3O4. 
 
4.3.2.2 Cytotoxicity of TMCN against MCF-7 Cells 
The cytotoxicity assay of the PLLA polymer and Fe3O4 nanoparticles encapsulated in 
the PLLA matrix was carried out by incubating the MCF-7 cells with the PLAN and 
FeLN. The MTT assay shows that the viability of the cells incubated with PLAN 
remained at about 90% relative to the non-toxic control during the period of 
incubation (Figure 4.11). This indicates that with a concentration of 500 μg/ml PLAN 
in the medium the PLLA polymer imparts low cytotoxic effects to cells. The viability 
of the cells incubated with 500 μg/ml FeLN in the medium shows a similar value as 



































Figure 4.11 Viability of MCF-7 cells after 4 d incubation in RPMI-1640 
medium with either PLAN (500 µg/ml) or FeLN (500 µg/ml), 50 to 
500 µg/ml TMCN, and 18 µg/ml of free tamoxifen (TAM). Data 
represent mean±SD, n=6. 
 
PLLA matrix also impart no cytotoxic effects to the cells. The effects of increasing 
TMCN concentration in the medium from 50 to 500 μg/ml on the MCF-7 cell 
viability is also shown in Figure 4.11. The cell viability decreases from 76% to 23% 
as the TMCN concentration increases from 50 μg/ml to 500 μg/ml after 4 d incubation 
at 37 °C. The decrease in cell viability with increasing TMCN concentration in the 
medium is due to the increase in TMCN uptake and the corresponding increase in 
intracellular tamoxifen concentration. Tamoxifen may also be released from TMCN 
in the medium and taken in by the cells, but this amount is likely to be significantly 
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less than that taken in via the TMCN due to the low solubility of the tamoxifen (see 
below). The cytotoxic activity of tamoxifen encapsulated in TMCN was also 
compared with that of free tamoxifen. In this experiment, an amount of free tamoxifen 
approximately equal to that encapsulated in 500 μg/ml of TMCN was added to the 
medium. The viability is much higher than that observed with TMCN (67% versus 
23%). This decrease in cytotoxicity is the result of the low free tamoxifen 
concentration in medium due to its low solubility and its high binding affinity to 
plasma proteins in the growth medium, as reported in literature (Cavallaro et al. 
2004). On the other hand, through the uptake of TMCN by the MCF-7 cells, the 
tamoxifen is directly released inside the cells which increases the intracellular 




A magnetic targeting carrier, TMCN containing the anti-estrogen modulator, 
tamoxifen, was successfully prepared and characterized. The TMCN with a particle 
size of ~200 nm were synthesized with solvent evaporation/extraction technique. The 
magnetic property of the TMCN was provided by the 6 nm superparamagnetic 
nanoparticles evenly distributed in the TMCN. The encapsulation efficiency for 
tamoxifen and Fe3O4 nanoparticles is about 60 % and 80 % respectively when less 
than 7.5 mg tamoxifen and 20 mg Fe3O4 nanoparticles were formulated in 100 mg 
PLLA in DCM. About 50% of the drug encapsulated in these TMCN is released into 
PBS containing a surfactant within 1 day. The TMCN can be readily taken in by 
MCF-7 cells and 182 pg TMCN was internalized into each MCF-7 cell over a 4 h 
incubation period with 500 µg TMCN/ml culture medium. With this concentration of 
TMCN in the culture medium, MCF-7 cancer cells exhibit morphological changes 
within 4 h and ~80% of the cells were no longer viable after 4 days. These results 











CHAPTER 5 SYNTHESIS OF FOLIC ACID 
FUNCTIONALIZED PLLA-b-PPEGMA 





The results in Chapter 4 show that colloidal carriers that encapsulate therapeutic agents in 
biodegradable polymers represent a very attractive approach to achieve controlled 
release. Furthermore, such carriers increase chemical stability, and avoid toxic side 
effects of the therapeutic agents. As such, colloidal carriers have been extensively 
employed to deliver drugs, genes, diagnostics and vaccines into specific cells/tissues of 
interest. However, efficient drug delivery with these systems may be compromised by 
two factors: a short blood half-life (i.e. rapid elimination from the circulation system by 
the phagocytic cells of the reticuloendothelial system) and nonspecific targeting. The 
rapid elimination of the carriers from the circulation stream is due to recognition by the 
phagocytic cells of the reticuloendothelial system (RES). Phagocytosis by elements of the 
RES is mediated by the adsorption of blood proteins (opsonins) onto the surface of the 
colloidal carriers. This phenomenon gives rise to the accumulation of the particulate drug 
carrier in the RES, such as in the liver and spleen. To obtain long-circulating colloidal 
drug carriers, the surface of the colloids has to be modified with hydrophilic, flexible, and 
nonionic polymers, such as poly(ethylene glycol) (PEG) (Peracchia et al. 1999; Moghimi 
et al. 2001; Mornet et al. 2004). 
To overcome the limitation of nonspecific targeting, cancer cell-specific ligands have 
been employed as targeting moieties to improve delivery and retention of colloidal drug 
carriers within the tumor tissues. Folic acid (FA) is a vitamin which has a high affinity 
for the folate receptor (dissociation constant (Kd) ~ 10-10 M), a 
glycosylphosphatidylinositol-anchored cell surface receptor that is overexpressed in 
many human tumors, including breast, ovary, endometrium, kidney, lung, head and neck, 
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brain, and myeloid cancer (Campbell et al. 1991; Weitman et al. 1992a; Weitman et al. 
1992b; Ross et al. 1994; Sudimack and Lee 2000). With proper design, folate-conjugated 
drugs or delivery vehicles also display high affinity for folate receptor which enables 
them to rapidly bind to these receptors and become internalized via an endocytic process. 
The attractiveness of folate has been further enhanced by its low immunogenicity, small 
size, ease of modification, compatibility with a variety of organic and aqueous solvents, 
and low cost (Lu and Low 2002). A variety of folate conjugates and complexes have been 
developed for tumor-specific targeting. These include radiopharmaceutical agents 
(Leamon et al. 2002), low molecular weight chemotherapeutic agents (Aronov et al. 
2003), liposomes with entrapped drugs (Gabizon et al. 1999), drug-loaded nanoparticles 
(Oyewumi and Mumper 2003; Liu et al. 2007), and plasmids (Reddy et al. 2002). 
However, the effectiveness of these folate targeting systems is limited by the number of 
FA molecules attached to the drug or delivery vehicle or by the topology of their 
structure. Multivalent interactions, the simultaneous binding of multiple ligands to 
multiple receptors, have been investigated to improve targeting of specific cell type. 
Dendrimer-based anticancer nanotherapeutics containing ~5 folate molecules have shown 
in vitro and in vivo efficacy in cancer cell targeting (Hong et al. 2007). The Kd between 
the nanodevices and folate-binding protein are dramatically enhanced through 
multivalency (~2,500- to 170,000-fold) (Hong et al. 2007). Folic acid conjugated 
polymers, such as PEG-b-poly(ε-caprolactone), PEG-b-poly(D,L-lactic-co-glycolic acid) 
have been used for making nanoparticles for targeted drug delivery (Saul et al. 2003; Yoo 
and Park 2004; Park et al. 2005). However, the effectiveness of these folate-targeted 
nanoparticles may be limited as there is only one functional group on each polymer 
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chain. Polymers with multifunctional groups are expected to increase the interaction of 
the nanoparticles and targeted site due to the multivalent interactions. 
In the present study, we report a method for preparing a biodegradable polymer with 
multifunctional groups, poly(L-lactic acid)-block-poly(poly(ethylene glycol) 
monomethacrylate), for cancer cell targeting. The pendent groups of PEG were then 
functionalized with FA. Colloidal carriers have been used for formulation and delivery of 
anticancer drugs, such as doxorubicin, paclitaxel, tamoxifen, and methotrexate 
(Nakanishi et al. 2001; Chawla and Amiji 2002; Cavallaro et al. 2003; Cavallaro et al. 
2004). In this study, superparamagnetic magnetic nanoparticles were chosen as the model 
agent for encapsulation in the colloidal carrier. Since magnetic resonance imaging (MRI) 
is recognized to be a noninvasive technique used to diagnose and monitor tumor growth 
in patients with cancer, the encapsulated magnetic nanoparticles can also be used as 
contrast agents for MRI. Hence, the colloidal carrier with encapsulated magnetic 
nanoparticles may enable real-time monitoring of carrier distribution with MRI. In this 
work, the physicochemical properties of the FA-conjugated colloid carrier were 
characterized and their efficacy in targeting MCF-7 cancer cells was demonstrated. 
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5.2 Materials and Methods 
5.2.1 Materials 
L-lactide (Sigma-Aldrich) was recrystallized twice from ethyl acetate before use. 
Poly(ethylene glycol) monomethacrylate (PEGMA) macromonomer (Mn ~ 360) (Aldrich) 
was passed through a silica gel column to remove the inhibitor and stored under an argon 
atmosphere at -10 C. N-hydroxysuccinimde (NHS) and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) were purchased from Fluka. 
Ethylenediaminetetraacetic acid (EDTA) disodium salt dehydrate, 2, 2’-bipyridyl (Bpy), 
copper(I) bromide, stannous octoate, folic acid dehydrate ethylene glycol (anhydrous), 2-
bromo-2-methylpropionyl bromide were purchased from Sigma-Aldrich. MCF-7 breast 
cancer cells and mouse macrophage cells (RAW 264.7) were purchased from ATCC. 
MTT, RPMI-1640 medium, fetal bovine serum, L-glutamine, penicillin and streptomycin 
were purchased from Sigma-Aldrich. All other solvents and chemicals were purchased 
from either Fisher Scientific or Sigma-Aldrich and used as received. 
5.2.2 Preparation of Double-headed Initiator 
The double-headed initiator, 2-hydroxyethyl 2’-methyl-2’-bromopropionate (HMBP), 
was prepared according to an earlier reported method with minor modification 
(Haddleton et al. 1997). 25 ml 2-bromo-2-methylpropionyl bromide was added slowly to 
250 ml of anhydrous ethylene glycol. The reaction mixture was refluxed for 4 h, filtered 
into 500 ml of distilled water and the product extracted into chloroform. After washing 
with water and sodium hydrogen carbonate and drying over magnesium sulfate the 
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product was isolated as a colorless liquid after the removal of the solvent and vacuum 
distillation at 64.5 °C and 20 Pa. The OH group in the HMBP was used to initiate ring 
opening polymerization of lactide while the Br group was used to initiate ATRP of 
PEGMA, as discussed below. 
5.2.3 Preparation of PLLA-b-PPEGMA 
5.2.3.1 2-bromo-2-methylpropionyl End Functionalized Poly(L-lactic acid) 
The synthesis of 2-bromo-2-methylpropionyl end functionalized poly(L-lactic acid) 
was performed by ring-opening polymerization of lactide in bulk using HMBP as an 
initiator and stannous octoate as a catalyst. Under a nitrogen atmosphere, 0.1 ml HMBP 
and 20 g of lactide were placed into a glass tube, and a freshly prepared solution of 
stannous octoate in anhydrous THF was added to the tube (molar ratio of lactide/stannous 
octoate =1000). The solvent was removed under vacuum overnight. The tube was purged 
with argon and then sealed in vacuo. The sealed tube was placed in an oil bath at 150 °C 
for 24 h. The obtained products were then dissolved in a small amount of chloroform and 
precipitated in an excess amount of acetone/hexane (volume ratio of 1:4) to remove the 
unreacted monomer. The resulting PLLA polymer was filtered and dried under reduced 
pressure. 
5.2.3.2 ATRP of PEGMA 
For the ATRP of PEGMA, the THF solvent and the monomer were purged with argon for 
20 min before use. 0.5 g of the poly(L-lactic acid) with 2-bromo-2-methylpropionyl 
group on one end was dissolved in 5 ml THF in a Pyrex tube, followed by the 
introduction of 5 ml PEGMA monomer, 20 mg CuBr and 58 mg 2, 2’-bipyridyl (Bpy) 
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into the solution under protection of argon. After further purging with argon for 5 min, 
the tube was sealed and the mixture was stirred at 30 °C. After 12 h polymerization, the 
mixture was poured into a large amount of DI water containing a small amount of EDTA 
disodium salt, which was used to remove the copper complexes. The precipitate was 
collected by filtration and dissolved in THF and re-precipitated with water twice in order 
to remove the PEGMA monomer and homopolymer, and then dried under reduced 
pressure. 
5.2.3.3 Conversion of the Terminal Hydroxyl Groups to Chloride 
Conversion of terminal hydroxyl groups into chloride was achieved by reaction with 
thionyl chloride (Zalipsky 1995). 0.4 g of the PLLA-b-PPEGMA was dissolved in 10 ml 
dry THF in a Pyrex tube with a magnetic stir bar. 0.2 ml of thionyl chloride and 0.5 ml of 
pyridine (to neutralize the HCl formed during the reaction) were then added to the 
solution. The tube was sealed and kept at room temperature under stirring. After 6 h, the 
mixture was poured into copious amount of water to precipitate the polymer. The 
precipitate was then washed with water several times and dried under reduced pressure. 


























Figure 5.1 Schematic representation of the synthesis of PLLA-b-PPEGMA with 
a double-headed initiator. 
 
5.2.4 Preparation of Folic Acid Functionalized PLLA-b-PPEGMA 
Polymeric Nanoparticles (PNP) with Encapsulated Magnetic 
Nanoparticles 
5.2.4.1 PNP with Encapsulated Magnetic Nanoparticles  
PLLA-b-PPEGMA polymeric nanoparticles with encapsulated Fe3O4 (MN/PNP) were 
prepared by the solvent evaporation/extraction technique in o/w emulsion. The Fe3O4 
magnetic nanoparticles were prepared according to a previous reported method (Sun et al. 
2004). The MN/PNP were prepared using the following procedure: 100 mg of PLLA-b-
PPEGMA, 20 mg of 6 nm Fe3O4 were dissolved in 8 ml dichloromethane and vortexed 
for 10 min to make the organic phase. The organic phase was then poured into 80 ml of 
stirred aqueous solution containing 1 % PVA as emulsifier. The mixture was sonicated 
for 120 s with an ultrasonic processor (Sonics, VCX 130 PB). The formed o/w emulsion 














































organic solvent. The MN/PNP were collected by centrifugation at 10,000 rpm for 10 
minutes and washed three times with DI water. The nanoparticles were resuspended with 
10ml water and freeze-dried (Edwards freeze dryer, ESM 1342) for two days. 
Fluorescent marker coumarin-6 loaded PLLA-b-PPEGMA polymeric nanoparticles 
(C6/PNP) were also prepared to enable visualization of the cellular uptake of the 
nanoparticles. The C6/PNP were prepared in the same method mentioned above except 
that the organic phase contains 0.05% (w/v) coumarin-6 as fluorescent marker instead of 
magnetic nanoparticles. 
5.2.4.2 PNP Surface Functionalized with Folic Acid 
The functionalization of the surface of PLLA-b-PPEGMA nanoparticle (PNP) with folic 
acid is shown schematically in Figure 5.2. The chloride groups on the nanoparticle 
surface were first converted into amino groups by reaction with an excess of ammonia, 
followed by reaction with folic acid in the presence of NHS and EDC. The folic acid 
functionalized MN/PNP nanoparticles (FA-MN/PNP) were prepared using the following 
procedure: 20 mg MN/PNP nanoparticles functionalized with chloride groups were 
dispersed in 10 ml water and placed in utrasonic bath for 5 min. 0.5 ml concentrated 
ammonia solution was then added and the mixture was stirred for 12 h at room 
temperature. The resulting particles were collected by centrifugation at 10000 rpm, 














Figure 5.2 Schematic representation of surface functionalization of PLLA-b-
PPEGMA nanoparticles with folic acid 
 
10 mg dried MN/PNP nanoparticles functionalized with amino group were added to the 
mixture of 0.5 ml of 0.1 M folic acid in DMSO, 6 mg of NHS and 30 mg EDC in 4 ml 
water and the mixture was then placed in an utrasonic bath for 5 min. The pH of the 
reaction mixture was adjusted to 9 with triethylamine. The reaction was allowed to take 
place for 4 h at 37 °C. The suspension was centrifuged and the precipitate was washed 
with water several times and dried under reduced pressure. The amount of folic acid 
bound onto the nanoparticles was determined from the colorimetric absorbance of the 
folic acid solution at 400 nm before and after the reaction (also taking into account the 
FA in the water wash). The folic acid functionalized C6/PNP nanoparticles (FA-C6/PNP) 
were similarly prepared as described above. 
5.2.5 Cell Culture Assay 
RAW 264.7 macrophage cells were routinely cultured in RPMI-1640 medium, 










100 µg/ml streptomycin at 37 C in 5% CO2 atmosphere. The MCF-7 breast cancer cells 
were cultured with the same method described in Section 4.2.6. 
For the qualitative study, cells were reseeded in the chambered cover glass system 
(LAB-TEKs, Nagle Nunc, IL). The medium was exchanged with 1 ml medium 
containing 200 µg/ml C6/PNP or FA-C6/PNP after cells were about 70% confluent. After 
4 h incubation at 37 C, the culture medium from each well was removed and the cells 
were washed four times with PBS and were then fixed with 75% ethanol for 15 min. The 
cells were further washed twice with PBS and the nuclei were counterstained with 
propidium iodide (PI) for 30 min. The cells were washed twice with PBS and then 
observed by confocal laser scanning microscope (CLSM) (Zeiss LSM 410) with an 
imaging software (Fluoview FV500). 
For the quantitative study, the nanoparticle uptake by MCF-7 cells was determined from 
the amount of iron in the cells. MCF-7 cells (1 ml) at a density of 5×104 cells/ml were 
seeded in a 24-well plate in the complete growth culture medium. After culturing in a 5% 
CO2 incubator for 24 h, the medium was exchanged with 1 ml medium with a specified 
concentration of FA-MN/PNP or MN/PNP. After incubation at 37 C for prescribed time 
periods, the cells were washed with PBS three times to remove the nanoparticles in the 
medium, and detached with trypsin-EDTA solution. After counting with a 
hemocytometer, the cells were collected by centrifugation, and the cell pellet was 
dissolved in 37% HCl at 60 C for 2h. The iron concentration was determined using 




FTIR spectra were obtained in a transmission mode on a Bio-Rad FTIR 
spectrophotometer (Model FTS135) under ambient conditions. The sample was prepared 
by placing one drop of liquid sample between two plates of sodium chloride. The drop 
forms a thin film between the plates. The spectrum was taken from 400 to 4000 cm-1. 
Typically, 64 scans at a resolution of 8 cm-1 were accumulated to obtain one spectrum. 
Gel permeation chromatography (GPC) to determine the molecular weight and 
distribution of the PLLA and PLLA-b-PPEGMA was carried out using a Waters GPC 
system equipped with a Waters 1515 isocratic HPLC pump and Waters 2414 refractive 
index detector. Polystyrene was used as a calibration standard. THF was used as the 
eluent at a flow rate of 1.0 ml/min.  
Other characterization methods, XPS, TGA, TEM and FESEM, were described in 
Section 3.2.4 and Section 4.2.4. 
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5.3 Results and Discussion 
5.3.1 Characterization of PLLA-b-PPEGMA 
The double-headed initiator, HMBP, was prepared in one step by using a commercially 
available chemical, 2-bromo-2-methylpropionyl bromide. Figure 5.3 shows the FTIR 
spectrum of this double-headed initiator. The spectrum shows a band at 3500 cm-1 due to 
O–H stretching. The symmetrical and unsymmetrical C–H stretching of methylene and  
 
 
























methyne groups is found at 2950 cm-1. The strong absorption band at 1736 cm-1 is 
attributed to C=O stretching of the of the ester group. The C–O stretching of the ester 
groups is found at 1170 cm-1 and C–OH stretching of the alcohol groups is found at 1110 
cm-1. The band at 644 cm-1 is attributed to C-Br stretching (Fomine et al. 1998). The OH 
group in the HMBP was used to initiate ring opening polymerization of lactide while the 
Br group was used to initiate ATRP polymerization of PEGMA, as discussed below. 
The PLLA polymer was synthesized by ring-opening melt polymerization of lactide 
using stannous octoate as catalyst and the hydroxyl group of HMBP as initiator. A 
mechanism of the ring-opening polymerization of lactide using a tin catalyst was 
suggested by Kissel et al. (Kissel et al. 1991). The Lewis acid character of the tin catalyst 
activates the ester carbonyl group in the lactide. The activated species then react with the 
alcohol initiator to form an unstable intermediate, which opens to become the ester 
alcohol. The propagation reaction proceeds by tin catalyst activation of another lactide 
carbonyl group and reaction with the hydroxyl end group. In our experiment, The PLLA 
polymer was synthesized from ring-opening polymerization of lactide at 150 °C which is 
lower than the melting point of the polymer (~175 °C). Hence, the polymer crystallized 
as it was formed, resulting in solid-state polymerization. The GPC result of the PLLA 
produced is shown in Figure 5.4a. The number average molecular weight (Mn) of the 




















Figure 5.4 GPC traces for (a) PLLA (b) PLLA-b-PPEGMA 
 
We have elected to use ATRP for the polymerization of PEGMA in the present work 
since it is a versatile technique which offers several advantages over other polymerization 
routes including control over molecular weight and molecular weight distribution (Narain 
2006). In addition, the polymers can be end-functionalized or block copolymerized upon 
the addition of other monomers. However, one drawback of ATRP is that control over the 
polymerization is gained at the cost of a decreased polymerization rate. Figure 5.4b 
shows the GPC result of the PLLA-b-PPEGMA. The Mn of the block copolymer 
calculated from the GPC was 27,400. The polydispersity of the block polymer is ~1.46, 
which is close to that of PLLA. The polymerization rate of PEGMA is much lower than 
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that reported in our earlier work which was carried out in aqueous medium (Hu et al. 
2006). A low polymerization rate was also reported in preparing PEGMA with ATRP in 
toluene (Lecolley et al. 2004). The difference in polymerization rate can be attributed to 
the solvent effect. Wang et al reported that water acts as an accelerator of ATRP (Wang 
et al. 1999; Wang et al. 2000) and Matyjaszewski et al. have shown that the use of polar 
solvents for ATRP resulted in an increase in the activation rate constant as well as a 
decrease in the deactivation rate constant (Matyjaszewski et al. 1999). 
The composition of the PLLA and PLLA-b-PPEGMA was analyzed using XPS. Three 
peak components are observed in the C 1s core-level spectrum of the PLLA (Figure 
5.5a). The peaks with the binding energy (BE) at 284.6, 286.3 and 288.7 eV are attributed 
to the carbon atoms from C-H, C-O and O=C-O groups. The area ratio of the three peaks 
C-H : C-O : O=C-O is 1.15:1.09:1, which are close the theoretical value of 1:1:1 expected 
for PLLA (see Figure 5.1). The Br 3d core level spectrum of PLLA shows a distinct peak 
with BE around 70 eV (Figure 5.5b), which confirms the presence of bromine atoms on 
the polymer chain. Figure 5.5d shows the C 1s core-level spectrum of PLLA-b-PPEGMA 
block polymer. The area ratio of the three peaks was obviously changed from that of 
PLLA (Figure 5.5a). The C-O peak is much more prominent than the other two peaks and 
the area ratio of the three peaks (C-H : C-O : O=C-O) is now 1.23:1.64:1, which is close 
to the theoretical ratio, 1.11:1.60:1, calculated from PLLA-b-PPEGMA with 21,200 
PLLA and 6,200 units of PPEGMA. The Br 3d core level spectra PLLA-b-PPEGMA 
shows a small but still discernible peak with BE around 70 eV (Figure 5.5e). This 
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Figure 5.5 XPS C 1s and Br 3d core level spectra of PLLA (a, b) and PLLA-b-PPEGMA (d, e), and Cl 2p spectra of PLLA-
















relative concentration of Br and the possible loss of some bromide atoms during the 
ATRP of PEGMA. 
The conversion of the terminal hydroxyl groups of PLLA-b-PPEGMA into chloride is 
readily achieved by treatment with thionyl chloride as shown by the Cl 2p spectra of 
PLLA-b-PPEGMA before and after treatment with thionyl chloride in Figure 5.5c, f 
respectively. Since there is no chloride in the PLLA-b-PPEGMA polymer, its Cl 2p 
spectrum shows no discernible peak (Figure 5.5c). After treatment with thionyl chloride, 
two peaks at the BE of 200 eV and 201.6 eV attributed to the C-Cl 2p3/2 and C-Cl 2p1/2 
can be seen (Figure 5.5f). These chloride groups were used as intermediate derivatives 
for further transformation of the PLLA-b-PPEGMA. 
5.3.2 Characterization of PNP 
Particle size is an important parameter for drug delivery carriers. It has been suggested 
that particles smaller than 1 µm can undergo capillary distribution and uniform perfusion 
at the desired target site (Arias et al. 2001). In this work, Fe3O4 nanoparticles were 
chosen as model agent to be encapsulated in the polymeric nanoparticles. Moreover the 
encapsulated Fe3O4 nanoparticles have a distinct advantage since they can be used as 
contrast agents for magnetic resonance imaging to visualize the distribution of MN/PNP 
in vivo (Tiefenauer et al. 1996; Choi et al. 2004). The FESEM image of the MN/PNP is 
shown in Figure 5.6. The nanoparticles appear spherical and well-separated and most of 





Figure 5.6 FESEM images of MN/PNP (prepared with 100 mg PLLA-b-
PPEGMA and 20 mg Fe3O4). 
Figure 5.7 shows the TEM image of the MN/PNP. The well-dispersed nature of the Fe3O4 
nanoparticles in the polymer matrix can be more clearly seen as black domains. The 
amount of Fe3O4 nanoparticles encapsulated in the MN/PNP was determined from TGA. 
The TGA residue of MN/PNP is red-brown in color, which indicates the oxidation of 
Fe3O4 to Fe2O3. It has been determined that the as-synthesized Fe3O4 nanoparticles 
contains 26% of organic components, which is mainly oleic acid (Section 4.3.1). The 
amount of Fe encapsulated in the polymer matrix was determined by TGA to be ~7.3 
wt%, which is equivalent to an encapsulation efficiency of 82%. The Fe3O4 content of 
folic acid functionalized MN/PNP was determined with the same method. The difference 
in the Fe3O4 content between MN/PNP and folic acid functionalized MN/PNP was 




Figure 5.7 FESEM of the MN/PNP (prepared with 100 mg PLLA-b-PPEGMA 
and 20 mg Fe3O4). 
 
5.3.3 Surface Functionalization of the PNP with Folic Acid 
The chloride groups on the PNP nanoparticles surface were transformed into amino 
groups by reaction with an excess of ammonia. The PNP nanoparticles were then 
functionalized with folic acid via carbodiimide which serves to link up the amino groups 
on the PNP surface with the carboxyl groups in folic acid. The success of this 
functionalization was ascertained by XPS. The wide scan and N 1s core-level spectra of 
the MN/PNP after conversion of chloride groups to amino groups were shown in Figure 
5.8. The wide scan spectrum (Figure 5.8a) of the nanoparticle shows a photoelectron line 
at BE about 400 eV and the N 1s core-level spectrum (Figure 5.8b) shows a prominent 
Chapter 5 
116 
peak, which indicates the success of conversion of the chloride groups to amino groups as 












Figure 5.8 (a) XPS wide scan, (b, c) N 1s and C 1s core level spectra of MN/PNP 
after treatment with ammonia solution for 12 h, (d) C 1s core level 
spectrum of FA-MN/PNP. 
 
The PNP nanoparticles functionalized with folic acid were also characterized with XPS. 
Figure 5.8c and d shows the C 1s core level spectra of the MN/PNP before and after 
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functionalization of folic acid. Compared to the spectrum of the PLLA-b-PPEGMA 
(Figure 5.5d), a new peak at BE of 285.8 eV can be found in Figure 5.8c, which is 
attributed to the C-N groups. After folic acid immobilization, the C 1s core level 
spectrum (Figure 5.8d) shows enhanced C-N groups which can be attributed to the 
immobilized folic acid. Further evidence of the surface immobilized of folic acid is 
provide by the emergence of the N=C-O and N-C=O peaks at BE of 287 and 288 eV 
respectively. The N:C atomic ratio, which was obtained from the peak area ratio of the N 
1s and C 1s spectra after correction with experimentally determined instrumental 
sensitivity factors, of the MN/PNP nanoparticles before and after folic acid 
immobilization is 0.025 and 0.068, respectively. The change in N:C ratio illustrates the 
changes in the surface composition of the nanoparticles after immobilization of folic acid 
and further confirms the success of folic acid immobilization. Based on the colorimetric 
method of folic acid quantification (Wuang et al. 2007), the amount of folic acid 
immobilized on the nanoparticles was estimated to be 58 mg/g nanoparticles. 
5.3.4 Cell Culture Assay 
Testing for cytotoxicity is the first step toward ensuring the biocompatibility of new 
materials. In this work, the MTT method was used to access the cytotoxicity of the 
nanoparticles. Two different types of mammalian cells were chosen for the in vitro 
cytotoxicity assay. The macrophage cells RAW 264.7 were chosen for testing the 
cytotoxicity to the normal cells, and the human breast cancer cells MCF-7 were chosen 
for testing the cytotoxicity to malignant cells. The MTT assay shows that the viability of 
the RAW 264.7 cells incubated with FA-MN/PNP up to a concentration of 500 μg/ml 
was ~ 87% relative to the non-toxic control during the period of incubation (4 days)  
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Figure 5.9 Viability of the RAW 264.7 macrophage cells and MCF-7 human 
breast cancer cells after 4 days incubation in RPMI 1640 medium 
containing FA-MN/PNP nanoparticles. Cell viability is expressed 
relative to the cells in the control experiment without any 
nanoparticles. Data represent mean±SD, n=6. 
 (Figure 5.9). This indicates that the FA-MN/PNP nanoparticles impart low cytotoxic 
effects to the RAW 264.7 cells. Figure 5.9 also shows that the viability of MCF-7 cancer 
cells remained above 76% when the concentration of FA-MN/PNP nanoparticles in the 
medium changed from 50 to 500 μg/ml. Polymers with similar structure, such as 
PPEGMA and poly(methacrylic acid) grafted with poly(ethylene glycol), have been 
reported to have low cytotoxicity (Foss and Peppas 2004; Hu et al. 2006). The higher 
cytotoxicity of FA-MN/PNP nanoparticles on MCF-7 cancer cells than on RAW 264.7 
cells may be attributed to a higher uptake of FA-MN/PNP nanoparticles by MCF-7 
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cancer cells than RAW 264.7 cells (see below). The folic acid on the nanoparticles 
surface enables the nanoparticles to rapidly bind to the folate receptors expressed on the 
surface of cancer cells and become internalized via receptor mediated endocytosis (Zhang 
et al. 2002; Leamon and Reddy 2004). Furthermore, it is easier for the nanoparticles to 
enter and accumulate in the cancer cells due to the enhanced permeability and retention 
(EPR) effect (Chawla and Amiji 2002; Chawla and Amiji 2003; Cavallaro et al. 2004; 
Fontana et al. 2005; Memisoglu-Bilensoy et al. 2005). 
The uptake of the nanoparticles by MCF-7 cells was visualized with confocal 
microscopy. Figure 5.10 shows the confocal microscopy images of MCF-7 cells after 4h 
incubation in medium containing 200 µm/ml of C6/PNP and 200 µm/ml of FA-C6/PNP. 
Figure 5.10 (a) and (d) were obtained from the FITC channel (fluorescence) and show the 
location of the fluorescent marker (green) inside the cells. In a control experiment, no 
fluorescence can be detected from cells incubated in medium with nanoparticles without 
encapsulation of coumarin-6, which indicates that the fluorescence signal comes from the 
coumarin-6 encapsulated in the nanoparticles rather than from the cells or polymer. From 
Figure 5.10 (a) and (d), we can clearly see that the cells incubated with FA-C6/PNP 
nanoparticles (Figure 5.10d) exhibit much stronger fluorescence intensity than those 
incubated with C6/PNP nanoparticles (Figure 5.10a) under the same condition, which 
indicates that FA-C6/PNP nanoparticles are more readily taken up by the MCF-7 cells 
than the C6/PNP. PI was used to stain nucleic acid and the results are shown in Figure 
5.10 (b) and (e) which were obtained from the PI channel (red). Figure 5.10 (c) and (f) 
shows the combination of FITC channel and PI channel. It can be clearly seen from these 
figures that the fluorescence of coumarin-6 encapsulated in the nanoparticles (green) is 
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closely located near the nuclei (red), which indicate that the nanoparticles have been 
taken up by the cells. 
 
 
Figure 5.10 Confocal microscopy images of MCF-7 cells after 4 h incubation in 
RPMI 1640 medium containing 200 µm/ml of C6/PNP (a-c) and 200 
µm/ml of FA-C6/PNP (d-f). a, d — images from FITC channel 
(green); b, e — images from PI channel (red); c, f — images combined 
with FITC and PI channels. Scale bar=10 μm. 
 
(a) (b) (c) 
(d) (e) (f) 
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For the quantitative study, the nanoparticle uptake by cells was determined from the 
intracellular iron concentration in the cells. Figure 5.11a shows that the MCF-7 cells 
incubated with FA-MN/PNP have much higher intracellular iron concentrations than 
those incubated with MN/PNP. The intracellular iron concentration of MCF-7 cells after 
4 h incubation with 25 µg/ml of FA-MN/PNP and MN/PNP is 6.1 and 0.72 pg/cell. As 
the FA-MN/PNP and MN/PNP contains 7.3 % Fe, the amount of FA-MN/PNP and 
MN/PNP nanoparticles internalized into the MCF-7 cells is calculated to be 83.3 and 9.8 
pg/cell, respectively. When the nanoparticle concentration in the medium is increased to 
500 µg/ml, the intracellular iron concentration increased to 21.0 and 9.1 pg/cell and the 
amounts of FA-MN/PNP and MN/PNP nanoparticles taken up by MCF-7 cells were 287 
pg/cell and 124 pg/cell, respectively. On the other hand, the intracellular iron 
concentrations of RAW 246.7 cells incubated with 500 µg/ml of either FA-MN/PNP or 
MN/PNP were less than 3 pg/cell (Figure 5.11b). These results indicate that the folic acid 
on the nanoparticle surface increases its uptake into cells with folate receptor 
overexpressed on the cell surface. The decrease in the iron uptake by the RAW 246.7 
cells can also attributed to the PEG side chains on the particles surface, which are 
effective in decreasing phagocytosis of the particles by RAW 246.7 cells (Mornet et al. 
2004). The low intracellular iron concentration of RAW 246.7 cells incubated with FA-
MN/PNP also illustrates that the immobilization of folic acid on the particle surface also 
will not enhance the elimination of the particles by macrophage cells. 
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Figure 5.11 Effect of MN/PNP and FA-MN/PNP concentration in the culture 
medium on intracellular iron concentration of MCF-7 cells (a) and 





























Figure 5.12 Uptake of MN/PNP and FA-MN/PNP by MCF-7 cells as a function of 
incubation time (nanoparticle concentration in medium = 200 μg/ml). 
Data represent mean±SD, n=3. 
Figure 5.12 shows the intracellular iron concentration of MCF-7 cells as a function of 
incubation time for up to 4 h using a nanoparticle concentration of 200 μg/ml. The 
intracellular iron concentration increased sharply and a plateau was established within the 
first 2 h of incubation with FA-MN/PNP. On the other hand, with the MN/PNP, the 
intracellular iron concentration increased gradually during the 4 h incubation. For FA-
MN/PNP, around 50 % of the intracellular iron accumulated after the 4 h period was 
taken up in the first 30 min, while for the MN/PNP, the corresponding value is only 15%. 
These results indicate that the folic acid on the nanoparticle surface facilitates the 
targeting of the specific cells by the nanoparticles. For the FA-MN/PNP, the folic acid on 
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nanoparticles surface enables the nanoparticles to rapidly bind to the folate receptors 
expressed on the surface of cancer cells and become internalized via receptor mediated 
endocytosis (Zhang et al. 2002; Leamon and Reddy 2004). On the other hand, 
nanoparticles without FA enter the cells via a slower nonspecific binding/penetration 




A new polymer, PLLA-b-PPEGMA, with a molecular weight of ~27k was successfully 
prepared using a double-headed initiator, HMBP. The hydroxyl groups of the PPEGMA 
block can be converted to chloride and amino groups to allow further functionalization. 
The PLLA-b-PPEGMA was used to prepare nanoparticles with encapsulated magnetic 
seeds via a solvent evaporation/extraction technique. By utilizing the functional groups 
on these nanoparticles, ~58 mg folic acid can be immobilized per gram of nanoparticles. 
The cytotoxicity tests showed that the viability of the RAW 264.7 cells incubated with 
PLLA-b-PPEGMA nanoparticles up to a concentration of 500 μg/ml remained ~ 87% 
relative to the non-toxic control during 4 days of incubation, which indicates low 
cytotoxic effects of this new polymer. When the folic acid functionalized PLLA-b-
PPEGMA nanoparticles were incubated with MCF-7 cancer cells, the intracellular iron 
concentration increases more rapidly and reaches a higher value than in case of 
nanoparticles without folic acid functionalization. Furthermore, the uptake of these 
PLLA-b-PPEGMA nanoparticles (with or without folic acid functionalization) by 
macrophages was significantly lower. These results demonstrate the effectiveness of the 
surface immobilized folic acid in targeting the MCF-7 cells. Since the surface of the 
PLLA-b-PPEGMA nanoparticles can be similarly functionalized with other targeting 
ligands besides folic acid, they have good potential to serve as an effective carrier for 









CHAPTER 6 CELLULAR RESPONSE TO 
MAGNETIC NANOPARTICLES “PEGYLATED” 






Magnetic nanoparticles have been deemed to have great potential in in-vivo 
biomedical applications including magnetic resonance imaging contrast enhancement 
(Bulte et al. 1999a; Lacava et al. 2001; Perez et al. 2004; Yan et al. 2004), targeted 
drug delivery (Lubbe et al. 1996c; Hafeli 2004), hyperthermia (Hafeli et al. 1997), and 
magnetic field assisted radionuclide therapy (Moroz et al. 2002). Because of their 
large surface area/volume ratio, nanometer-sized iron oxide cores tend to agglomerate 
into large clusters and adsorb plasma proteins. When nanoparticles agglomerate or are 
covered with adsorbed plasma proteins, they not only lose the specific properties 
associated with their nanometer dimensions, but can also be quickly cleared by 
macrophages and be accumulated in the reticuloendothelial system before they can 
reach the target cells (Allemann et al. 1993). 
One possible approach to increase the circulation time of nanoparticles in the blood 
stream is to modify the particles with poly(ethylene glycol) (PEG). Surfaces covered 
with PEG have proven to be nonimmunogenic, nonantigenic, and protein resistant 
(Harris and Zalipsky 1997; Zhang et al. 1998). The “grafting to” technique has been 
successfully used to immobilize PEG on iron oxide for biocompatibility (Zhang et al. 
2002; Kohler et al. 2004). However, this technique often leads to low grafting density 
and low film thickness, as the polymer molecules must diffuse through the existing 
polymer film to reach the reactive sites on the surface. In contrast, the “grafting from” 
approach would be more suitable for achieving high stability of the polymer layer and 
high graft density (Zhao and Brittain 2000). Progress in polymer synthesis techniques 
such as ATRP and RAFT-mediated polymerization also makes it possible to produce 
polymer chains with controllable lengths.  
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MnFe2O4 and Fe2O3 core/polystyrene shell nanoparticles have been synthesized via 
the ATRP technique (Vestal and Zhang 2002; Wang et al. 2003). The linear polymeric 
molecules attach to the surface of metal oxide cores through linker molecules (the 
initiator) via the COOH  group. This noncovalent linkage cannot offer a permanent 
linkage for the hydrophilic polymer. In a biological system, the hydrophilic polymer 
chains will be extended, and a dynamic exchange between the polymeric chain and 
other competing molecules possessing a COOH  such as peptides and amino acids 
in the biological system could lead to the dissociation of the polymeric chains from 
the core surfaces. To solve this problem, divinylbenzene was employed for cross-
linking the linear polymer chain to improve the stability of the core/shell 
nanoparticles (Li et al. 2004). However, in such a system, the particles would be 
aggregated due to cross-linking of polymer chains from different particles by 
divinylbenzene. 
In this work, we applied a copper-mediated ATRP technique to graft polymerize 
poly(ethylene glycol) monomethacrylate (PEGMA) on Fe3O4 nanoparticles via a 
silane initiator, [4-(chloromethyl)phenyl]trichlorosilane (CTS). Poly(poly(ethylene 
glycol) monomethacrylate) (PPEGMA) has been used to conjugate with proteins to 
increase their plasma half-lives and stability (Lecolley et al. 2004; Tao et al. 2004). It 
has also been used to functionalize surfaces to increase their tissue and blood 
compatibility, and increase their resistance to protein fouling (Chen et al. 2003; Li et 
al. 2003; Xu et al. 2005). We expect the following advantages from the PEGylation of 
nanoparticles with PPEGMA via ATRP: higher polymer density on the particle 
surface, controllable molecular weight, and more active groups for further 
functionalization. The uptake of PPEGMA functionalized nanoparticles by 
macrophage cells was also compared to that of the pristine Fe3O4 nanoparticles to 
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6.2 Materials and Methods 
6.2.1 Materials 
Benzyl ether, 1, 2-hexadecanediol, oleic acid, oleylamine, iron(III) acetylacetonate, 
[4-(chloromethyl)phenyl]trichlorosilane (CTS), 2, 2’-bipyridyl (Bpy), and copper(I) 
chloride were purchased from Aldrich Chemical Co. and used as received. Pyridine 
was dried over potassium hydroxide and distilled before use. Toluene was dehydrated 
with 4 Å molecular sieves before use. PEGMA macromonomer (Mn ~ 360) was 
passed through a silica gel column to remove the inhibitor and stored under an argon 
atmosphere at -10 C. Mouse macrophage cells (RAW 264.7) were purchased from 
ATCC. RPMI-1640 medium, fetal bovine serum,l-glutamine, penicillin and 
streptomycin were purchased from Sigma. All other solvents and chemicals were 
purchased from either Fisher Scientific or Aldrich and used as received. 
6.2.2 Surface Initiated Atom Transfer Radical Polymerization 
The synthesis of nanoparticles was described in Section 4.2.2. The magnetic 
nanoparticles with the initiator, CTS, for copper-mediated ATRP were prepared by 
self-assembled deposition method (Figure 6.1). A total of 20 mg of nanoparticles was 
first dispersed in 20 ml of dry toluene, and then 200 μl of dry pyridine and 50 μl of 
CTS were added to the nanoparticle suspension under the protection of argon. The 
mixture was sonicated for 1 h, and then the flask was opened to the air and sonicated 
for another 2 h at room temperature. The resulting CTS-immobilized nanoparticles 
were isolated with a centrifuge and washed with toluene in the presence of 1% of 
pyridine twice to remove the residue initiator. The CTS-immobilized nanoparticles 


















The surface initiated polymerization of PEGMA was carried out as follows (Figure 
6.1): the CTS-immobilized nanoparticles and 4 ml of deionized water were introduced 
into a Pyrex tube containing a magnetic stir bar. The suspension was sonicated for 10 
min to get a uniform suspension and followed by the addition of 2 ml of PEGMA 
monomer. The mixture was purged with argon for 15 min, and then CuCl (20 mg) and 
Bpy (67 mg) were added. After purging with argon for another 10 min, the Pyrex tube 
was sealed and kept in a 30 oC water bath under stirring. After prescribed 
polymerization times, the reaction was stopped by adding ethanol at a solution/ethanol 
ratio of 1:5. The modified Fe3O4 nanoparticles were collected by centrifuging at a 
speed of 20,000 rpm. The collected nanoparticles were re-dispersed in ethanol and 
centrifuged at a speed of 1000 rpm for 5 min to remove any Cu(II) precipitate formed 
in the ATRP process. The nanoparticles were then collected by centrifuging at 20,000 
rpm and subjected to repeated cycles of washing with ethanol and centrifugation to 




Figure 6.1 Schematic representation for the synthesis of PEGMA-coated 
magnetic nanoparticle by surface-initiated ATRP. 
 
6.2.3 Cell Culture 
Mouse macrophage cells (RAW 264.7) were used to test the intracellular uptake of 
the magnetic nanoparticles. The cells were routinely cultured with the same method 
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described in Section 5.2.5. The cultured cells were washed with PBS and detached 
with trypsin-EDTA solution. The cells were then collected by centrifugation and 
resuspended with the medium containing nanoparticles at a concentration of 0.2 
mg/ml to achieve a cell concentration of 105 cells/ml. The cells were then seeded in 
24-well culture plates. In the control experiment, the cells were cultured in the 
medium at the same cell concentration but without magnetic nanoparticles. After 
incubation at 37 C for prescribed time periods, the cells were washed with PBS three 
times to remove the nanoparticles in the medium, and were detached with trypsin-
EDTA solution. After counting with a hemocytometer, the cells were collected by 
centrifugation, and the cell pellet was dissolved in 37% HCl at 60 C for 2 h. The iron 
concentration was determined using inductively coupled plasma-mass spectroscopy 
(ICP-MS, Perkin-Elmer Elan 6100). 
6.2.4 Characterization 
The hydrodynamic size of the PPEGMA-immobilized magnetic nanoparticles was 
determined by dynamic light scattering (DLS) using a 90 plus particle size analyzer 
(Brookhaven Instruments). The molecular weight of the PPEGMA brushes grafted on 
the magnetic nanoparticle surface was determined with GPC as described in Section 
3.2.6. The PPEGMA polymer was separated from the nanoparticles surface by 
dissolving the Fe3O4 core and initiator with 10% HF for 5 h. 1 M NaOH was then 
used to neutralize the HF. After freeze-drying, the polymer was redissolved in 
tetrahydrofuran (THF) and centrifuged to remove the salts. The polymer was 
recovered after removal of the THF under reduced pressure. Other characterization 
methods, XPS, TGA, VSM, FTIR and TEM, were described in Section 3.2.4, Section 
4.2.4 and Section 5.2.6. 
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6.3 Results and Discussion 
6.3.1 Physical Properties of the Magnetic Nanoparticles 
Magnetic particles obtained under different synthetic conditions may display very 
different properties, such as particle size, shape, composition, magnetic properties, 
and so on. In the present work, the Fe3O4 magnetic nanoparticles were synthesized via 
high-temperature organic phase decomposition of an iron precursor, and the TEM 
image of these nanoparticles is shown in Figure 6.2. It can be seen from Figure 6.2 
that the particles are quite uniform with a particle size of 6.2±0.7 nm. The magnetic 
nanoparticles disperse well in organic solvents due to the presence of oleic acid on the 
particle surface. The degree of dispersion of the nanoparticles on drying is relatively 
high. The nanoparticles seen in Figure 6.2 are well-separated from their neighbours. 
 






















Figure 6.3 Field dependent magnetization at 25 °C for (a) pristine magnetic 
nanoparticles, (b) and (c) PPEGMA-immobilized nanoparticles 
after polymerization time of 2 and 4 h respectively. 
 
The saturation magnetization value of the nanoparticles as determined by the VSM is 
52 emu/g at 25 C (Figure 6.3a). After correcting for the oleic acid content (~26%), 
the saturation magnetization value is 70 emu/g of Fe3O4, which is lower than the bulk 
magnetite value of 90 emu/g (Binh et al. 1998). This reduction in magnetization may 
be the result of noncollinear spins at the nanoparticle surface. From Figure 6.3a, no 
hysteresis curve was observed which indicates the characteristic superparamagnetic 
behavior of the nanoparticles under room temperature, i.e., the nanoparticles would 
not retain any magnetism after removal of the magnetic field. These nanoparticles 
with superparamagnetic property have been used as MR T2 contrast agents. Each of 
these small superparamagnetic nanoparticles contains a single magnetic domain. In 
their natural state, the magnetic moments of these magnetic domains are oriented 
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randomly, but in the presence of an external magnetic field, magnetic moments of 
these domains are aligned along the field. As a result, magnetic susceptibility of a 
system with such nanoparticles usually far exceeds that of paramagnetic materials, 
such as Gd chelate which are widely used as T1 contrast agents (Kuperman 2000). 
6.3.2 Surface-initiated ATRP of PEGMA 
The chemical composition of the pristine and CTS-immobilized nanoparticles was 
analyzed by FTIR (Figure 6.4). The FTIR spectrum of the pristine magnetic 
nanoparticles (Figure 6.4a) exhibits strong bands in the low frequency region (at 410 
and 580 cm-1) due to the iron oxide skeleton, which are highly consistent with the 
spectrum of magnetite (Schwertmann and Cornell 1991; Gupta and Curtis 2004). The 
spectrum also shows characteristic absorption bands of oleic acid on the magnetic 
nanoparticle surface, such as that at 1424 cm-1 for alkanes and at 2856 and 2925 cm-1 
for CH2 groups (Pouchert 2001). However, from Figure 6.4a, the symmetric COO- 
stretch band at 1410 cm-1 cannot be differentiated from the 1424 cm-1 band. Similarly, 
the 1540 cm-1 band due to the asymmetric COO- stretch is not clearly discernible. The 
C=O stretching frequency of the oleic acid ligand usually at ~1700 cm-1 is also not 
observed in the spectrum. This absence can be attributed to the bonding of the oleic 
acid ligand to the nanoparticle surface through the COO- functionality. Similar results 
of the “missing” band at ~1700 cm-1 were also observed for para-substituted benzoic 
acid adsorbed on MnFe2O4 nanoparticles (Vestal and Zhang 2003). The FTIR 
spectrum of CTS-immobilized nanoparticles (Figure 6.4b) shows a band at 1046 cm-1 
attributed to the characteristic Si-O stretch absorption (von Werne and Patten 2001). 
The band at 694 cm-1 can be assigned to the CH2 group on the CTS, and the band at 
1485 cm-1 can be assigned to the benzene ring (Pouchert 2001). The disappearance of 
the bands observed in the pristine Fe3O4 spectrum mentioned above is due to the  
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Figure 6.4 FTIR spectra of (a) pristine magnetic nanoparticles, (b) CTS- 
immobilized nanoparticles, (c) PPEGMA-immobilized 
nanoparticles after polymerization time of 4 h. 
 
reaction of Si-Cl in CTS with the COOH  group of oleic acid which results in 
displacement of oleic acid from the surface of the magnetic nanoparticles into the 
solution. The FTIR spectrum of the magnetic nanoparticles modified with PPEGMA 
(Figure 6.4c) shows a broad band at 1130 cm-1 attributed to the C-O-C ether stretch 
band, and a band at 1732 cm-1 assigned to the stretch band of C=O. The spectrum also 
displays a strong band around 2912 cm-1 corresponding to the CH2 stretching 
vibrations. The CH2, C-O-C and C=O absorption bands provide strong evidence that 
the magnetic nanoparticles have been modified with PEGMA. No strong absorption 
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band at around 1630 cm-1, which is the characteristic band for C=C stretching 
vibration of the PEGMA monomer, can be found from Figure 6.4c. The absence of 
C=C stretching vibration further confirms the graft polymerization of the PEGMA 
monomer on the magnetic nanoparticles. 
Immobilization of CTS on the surface of magnetic nanoparticles is also confirmed 
with XPS. The photoelectron lines at binding energy (BE) of about 53, 284, 530 and 
710 eV which are attributed to Fe 3p, C 1s, O 1s and Fe 2p respectively are observed 
in the wide scan spectrum of the pristine magnetic nanoparticles (Figure 6.5a). Two 
peak components are observed in the C 1s core-level spectrum of the pristine 
magnetic nanoparticles. The peak at about 284.6 eV is attributed to C-C and C-H and 
the peak at 288.7 eV is attributed to COOH. The area ratio of the two peaks is 16.4:1 
which is close to the theoretical ratio of 17:1 for oleic acid (Figure 6.5b) indicating 
that the magnetic nanoparticle is well covered with the oleic acid layer. In addition to 
the photoelectron lines in Figure 6.5a, another three photoelectron lines at BE about 
100, 150 and 200 eV which can be attributed to Si 2p, Si 2s and Cl 2p are observed in 
the wide scan spectrum of CTS-immobilized nanoparticles (Figure 6.5c). The C 1s 
core-level spectrum of CTS-immobilized nanoparticles can be curve-fitted with three 
peak components having BE at about 283.9, 284.6, and 286.2 eV, attributable to the 
C-Si, C-C/C-H, and C-Cl species, respectively. The area ratio of the three peaks is 
0.9:4.9:1. The  - * shake-up satellite associated with the aromatic ring of CTS is 
also discernible at a BE of about 291 eV (Figure 6.5d). The appearance of the C-Si 
and C-Cl species, as well as the  - * shake-up satellite, confirms the presence of 
CTS immobilized on the nanoparticles surface. Figure 6.5e shows the Cl 2p spectrum 


















Figure 6.5 (a, b) XPS wide scan and C 1s core level spectra of pristine 
magnetic nanoparticles; (c-f) XPS wide scan and C 1s, Cl 2p and Si 
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and 201.6 eV are assigned to C-Cl 2p3/2 and C-Cl 2p1/2 respectively. The doublet at 
about 197.1 and 198.7 eV is assigned to Cl- 2p3/2 and Cl- 2p1/2. The presence of a 
small amount of Cl- ions on the nanoparticle surface can be attributed to the 
adsorption of Cl- from CTS onto the nanoparticle surface. Figure 6.5f shows the Si 2p 
spectrum of the CTS-immobilized nanoparticles. The [Si]:[C] ratio, as determined 
from the Si 2p and C 1s core level spectral area ratio, is about 1:7.3, which is close to 
theoretical value of 1:7 for CTS. 
The XPS wide scan spectrum of the Fe3O4 nanoparticle after surface grafting with 
PPEGMA (Figure 6.6a) shows two prominent photoelectron lines at binding energy of 
about 284 and 530 eV which are attributed to C 1s and O 1s respectively. The absence 
of photoelectron lines of Fe indicates that the PPEGMA layer immobilized on the 
surface of the magnetic nanoparticles is thicker than the XPS probing depth (~5 nm). 
The photoelectron line for copper at about 930 eV is not found in Figure 6.6a which 
indicates that the copper from CuCl used in the ATRP process is not retained on the 
nanoparticle. In Figure 6.6a, a very weak photoelectron line at BE of 200 eV is 
discernible. This is assigned to the preserved active chlorine groups from ATRP. The 
C 1s core-level spectrum of the PPEGMA-immobilized nanoparticles can be curve-
fitted with three peak components having BE at about 284.6, 286.2, and 288.3 eV, 
attributable to the C-C/C-H, C-O, and O=C-O species, respectively (Figure 6.6b). The 














Figure 6.6 (a) XPS wide scan and (b) C 1s core level spectra of PPEGMA-
immobilized nanoparticles after polymerization time of 4 h. 
 
The pristine magnetic nanoparticles disperse well in organic solvents such as toluene 
and hexane. After surface grafting with PPEGMA, the magnetic nanoparticles can be 
dispersed in ethanol as well as aqueous solvents forming a stable brown solution. No 
precipitation of the magnetic nanoparticles was observed even after dispersion in 
ethanol for 4 months. The hydrodynamic size of the PPEGMA-immobilized 
nanoparticles after 2 h polymerization was measured to be 26±5 nm, which further 
confirms that there is minimal aggregation between these particles in aqueous media. 
The molecular weight (Mn) of the PPEGMA was determined by GPC to be 14,100 
after a polymerization time of 2 h. The surface chain density of PPEGMA is 
calculated to be 0.7 chains/nm2, which is close to the value reported for ATRP of 
PEGMA on Si(111) surface (Xu et al. 2005). 
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TGA studies have also been carried out for the nanoparticles modified with oleic acid, 
CTS, and PPEGMA. The magnetic nanoparticles after each stage of modification give 
their distinctive TGA curves, which provide indications of the amount of initiator and 
PPEGMA on the magnetic nanoparticles. The TGA curve of the pristine magnetic 
nanoparticles (Figure 6.7a) shows a weight loss of about 23% after the magnetic 
nanoparticles have been heated to 700 C. The residue is red-brown in color, which 
indicates the oxidation of Fe3O4 to Fe2O3. The oxidation of Fe3O4 to Fe2O3 results in 
an increase in the weight of the residue. Assuming that all Fe3O4 has been  
 






















Figure 6.7 TGA curves of (a) pristine magnetic nanoparticles, (b) CTS-
immobilized nanoparticles, (c), (d), (e) PPEGMA-immobilized 
nanoparticles after polymerization time of 1 h, 2 h and 4 h 




oxidized to Fe2O3, the weight of organic fraction, which is mainly oleic acid (deduced 
from the XPS result), is calculated to account for 26% weight of the magnetic 
nanoparticles. The TGA curve of the magnetic nanoparticles with immobilized CTS 
shows a slower rate of weight loss (Figure 6.7b) between 200 °C and 550 °C 
compared to that of the pristine magnetic nanoparticles. The FTIR results have 
indicated that the most of the oleic acid would have been displaced by CTS in the 
immobilization process. Hence the weight loss seen in Figure 6.7b would be due to 
the oxidation of the CTS initiator. After oxidation of the initiator molecule, the SiO2 
ash will remain in the residue. From the residual weight, it is estimated that the 
initiator accounts for about 33% of the weight of the CTS-immobilized nanoparticles. 
Parts c-e of Figure 6.7 show the TGA curves of PPEGMA-immobilized nanoparticles 
obtained with a polymerization time of 1, 2 and 4 h respectively. These curves show a 
two-stage weight loss upon heating in air. As shown in Figure 6.7e, the first stage 
shows a weight loss of about 59% completed at 350 °C, while the second stage 
accounts for another 24% of the weight. This two-stage weight loss suggests that the 
poly(ethylene glycol) side chains are first eliminated followed by the 
poly(methacrylate). The amount of polymer on the magnetic nanoparticle surface 
increases with polymerization time. The weight loss of PPEGMA-immobilized 
nanoparticles is ~60% after 1 h polymerization and increases to ~75% after 2 h 
polymerization. With a 4 h polymerization time, the viscosity of the reaction mixture 
becomes very high as a result of the increased amount of polymer on the nanoparticle 
surface as well as some homopolymerization of the PEGMA in solution. The weight 
loss of the PPEGMA-immobilized nanoparticles after 4 h polymerization is ~83%. 
The PEGMA ATRP from the magnetic nanoparticles exhibited the characteristics of a 
controlled/“living” polymerization. The weight ratio of the PPEGMA/Fe3O4 
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calculated from the TGA results (shown in Table 6.1) shows a linear increase of 
polymer on the nanoparticle surface in the first 2 h, but after 2 h polymerization, this 
ratio is a little lower than the value expected from a linear increase. This deviation is 
attributed to the increasing viscosity of the mixture with polymerization time which 
inhibits the diffusion of the PEGMA monomer to the nanoparticle surface. 
Table 6.1 PPEGMA/Fe3O4 weight ratio of CTS-immobilized magnetic 
nanoparticles after polymerization with PEGMA  
Polymerization time (h) 0 1 2 4 
PPEGMA/Fe3O4 weight 
ratio 0 1.52 3.15 5.51 
 
The magnetization curves of the PPEGMA-immobilized nanoparticles are shown in 
Figure 6.3. The saturation magnetization value can be adjusted through control of the 
polymerization time which in turn determines the thickness of the PPEGMA shell. 
The saturation magnetization value decreases from the 52 emu/g for the pristine 
nanoparticles to 19 and 11 emu/g after 2 and 4 h polymerization respectively. On the 
basis of per unit weight of Fe, the average saturation magnetization values for the 
pristine and PPEGMA-immobilized particles are quite similar, at 105±11 emu/(g Fe). 
These values are deemed sufficient for biological applications and the magnetization 
values for magnetic nanoparticles coated with biocompatible substances, such as 
dextran, starch, gold, silica, nitrilotriacetic acid and PEG, have been reported to be 5-
22 emu/g (Bulte et al. 1999a; Brusentsov et al. 2001; Tartaj and Serna 2003; Lu et al. 
2004; Mikhaylova et al. 2004; Xu et al. 2004). The grafting of PEGMA onto magnetic 
nanoparticle surface via ATRP has the advantages of being a controllable 
polymerization process and providing more reactive groups (-OH, -Cl) for further 
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functionalization (Zalipsky 1995). The cellular response to such functionalized 
magnetic nanoparticles is reported in the following section. 
6.3.3 Cell Uptake 
Figure 6.8 shows the optical microscopy images of macrophage cells incubated with 
pristine and PPEGMA-immobilized nanoparticles obtained after 2 h of 
polymerization. The macrophage cells, after culturing in the medium containing 
pristine magnetic nanoparticles for 1 day, are totally covered by the pristine magnetic 
nanoparticles (Figure 6.8b). A black layer of magnetic nanoparticles was formed on 
the bottom of the culture flask due to the precipitation of the nanoparticles in the 
culture medium. However, a clean area around each macrophage cell can be observed, 
indicating that the nanoparticles surrounding the cells were being cleaned up by the 
cells. After 4 days incubation, almost all the pristine magnetic nanoparticles were 
cleaned up by the macrophage cells (Figure 6.8c). This figure also shows that there 
was no distinct change in morphology, compared with the cells in the control 
experiment without nanoparticles (Figure 6.8a). Figure 6.8c also shows that the cell 
number has increased compared to Figure 6.8b. The cells incubated in the medium 
containing PPEGMA-immobilized nanoparticles after 1 day is shown in Figure 6.8d. 
Since the PPEGMA-immobilized nanoparticles are well dispersed in the medium, no 
black precipitate can be observed. The cells incubated with the PPEGMA-
immobilized nanoparticles show similar morphology as the control cells and are well 
spread out, which suggests cell motility. After 4 days of incubation, the microscopy 
image remains similar to Figure 6.8d, except for a greater abundance of cells. Hence, 
whether the cells take up the PPEGMA-immobilized nanoparticles or not is not 
obvious from these microscopy images. The ICP-MS results below will provide 





Figure 6.8 (a) RAW 264.7 
cells in control culture (without 
any nanoparticles) after 1 day, 
(b) cells after culturing in 
medium containing pristine 
magnetic nanoparticles (0.2 
mg/ml) for 1 day and (c) for 4 
days, (d) cells after culturing in 
medium containing PPEGMA-
immobilized nanoparticles (0.2 
mg/ml) for 1 day. The PPEGMA-
immobilized nanoparticles were 
obtained after polymerization 
time of 2 h. Scale bar=40 μm. 
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Figure 6.9 Viability of the macrophage cells cultured in medium containing 
0.2 mg/ml magnetic nanoparticles. Cell viability is expressed 
relative to the cells in the control experiment without any 
nanoparticles. 
 
Cell viability is calculated from the number of cells incubated in the medium 
containing nanoparticles compared with that in the control experiment without 
nanoparticles. The viability of the cells after incubation in medium containing 0.2 
mg/ml of pristine and PPEGMA-immobilized nanoparticles is compared in Figure 
6.9. The viability of the cells incubated with PPEGMA-immobilized nanoparticles 
remained at >93% relative to the control during the period of incubation. This 
indicates that the PPEGMA-immobilized nanoparticles impart no cytotoxic effects to 
cells at a concentration of 0.2 mg/ml. On the other hand, when the cells were 
incubated with pristine nanoparticles, 30% loss in viability was observed in the first 2 
days. The viability gradually increased in the next 3 days to about 90% in the fifth 
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day. This decrease in cytotoxicity with incubation time can be attributed to the 
decrease in the concentration of nanoparticles in each macrophage cell. At the 
beginning, the macrophage cells were almost covered with nanoparticles (Figure 
6.8b), and nanoparticles were being taken up by the cells. With the progressive cell 
division, the amount of nanoparticles in each cell will gradually decrease (Figure 
6.8c) and the cytotoxic effects of the nanoparticles will diminish. 
The extent of magnetic nanoparticles uptake by macrophage cells after incubation in 
the medium containing pristine and PPEGMA-immobilized nanoparticles was tested 
using ICP-MS. Figure 6.10 shows that the amount of pristine magnetic nanoparticles 
internalized into the cells normalized by the number of cells decreased from 154 
pg/cell in the first day to 58 pg/cell after 5 days of incubation. This decrease is clearly 
due to the increase in the number of cells. These values were much higher than that 
reported for the uptake of 10 nm nanoparticles prepared via coprecipitation of Fe2+ 
and Fe3+ by addition of ammonia solution in aqueous solution (Qu et al. 1999). For 
these particles, the uptake ranged from 4 to 12 pg/cell. This difference in uptake is due 
to the different surface properties of the nanoparticles obtained under different 
synthetic conditions. The presence of OH and NH2 on the surface of these 
nanoparticles help them disperse in aqueous solution and decrease the aggregation 
(Qu et al. 1999; Huang et al. 2003). On the other hand, the OH groups on surface of 
nanoparticles synthesized via high-temperature organic phase decomposition method 
used in the present work decreased greatly as the nanoparticles were heated to a high 
temperature (300 C), and the alkane chains of the oleic acid on the nanoparticle 
surface increases its hydrophobicity. Both factors account for the higher uptake of 
pristine magnetic nanoparticles observed in the present work. The uptake of 
PPEGMA-immobilized nanoparticles by macrophage cells was less than 2 pg/cell 
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during the 5 days (Figure 6.10b). This vast reduction in uptake is attributed to the fact 
that PEG side chains prevent the nanoparticles from aggregation, increase their 
resistance to the adsorption of proteins from the culture medium and decrease their 
interaction with proteins on macrophage cells membrane.  








































Figure 6.10 Iron concentration in RAW 264.7 cells cultured in medium 
containing (a) pristine magnetic nanoparticles, (b) PPEGMA-
immobilized nanoparticles obtained after polymerization time of 2 
h. 
 
In the body, the macrophages of the mononuclear phagocyte system are widely 
distributed and strategically placed to recognize and clear invading microorganism or 
particles (Mornet et al. 2004). As such, injected nanoparticles face rapid elimination 
from the blood system due to the clearing action of the macrophages. The clearance 
mechanism by the macrophage cells is reported to comprise the following two steps 
(Mornet et al. 2004): plasma proteins first adsorb onto the surface of the nanoparticles 
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and these proteins are capable of interacting with the specialized plasma membrane 
receptors on macrophages, thus promoting particle recognition by these cells. The 
endocytosis/phagocytosis of these particles by the macrophage cells would then 
follow. Therefore, the adsorption of the proteins onto the particle surface plays a key 
role during the clearance process. In our work, we have utilized PPEGMA 
immobilization onto the nanoparticle surface in order to prevent proteins and 
macromolecules from depositing on the surface. The PPEGMA renders the surface 
neutral and hydrophilic. At the same time, the PEG side chains of the PPEGMA are 
highly flexible in aqueous solution, and if the macromolecules come close to the 
surface, the conformational degree of freedom for the polymer will be dramatically 
reduced resulting in an entropic repulsion between the surface and the 




A new method for PEGylation of magnetic nanoparticles was successfully carried out 
in this work. The magnetic nanoparticles were first modified with the CTS initiator 
and PEGMA was then grafted onto the surface of magnetic nanoparticle via copper-
mediated ATRP. The grafted PPEGMA chains are stable and enable the modified 
magnetic nanoparticles to disperse well in aqueous solutions. Moreover, the uptake of 
the magnetic nanoparticles by macrophage cells is greatly reduced after surface 
grafting with PPEGMA. The morphology and viability of the macrophge cells 
cultured in a medium containing 0.2 mg/ml of PPEGMA-immobilized magnetic 
nanoparticles were similar to those of the cells in the control experiment without any 
nanoparticles. The uptake of nanoparticles by the macrophage cells was greatly 
reduced from 158 pg/cell to <2 pg/cell after grafting with PPEGMA. This method 
provides opportunities for grafting a dense layer of hydrophilic polymer brushes onto 
the magnetic nanoparticles surface, and the preserved active chlorine groups and the -
OH pendant groups of the PPEGMA can serve as reactive sites for further 














A number of surface and bulk functionalization techniques to confer particles with 
suitable properties for diagnosing and eliminating malignant cells were developed. 
Microbeads surface functionalized with quaternary ammonium salts were synthesized 
for eliminating bacterial and fungal cells. Nano-sized particles were developed for 
diagnosing and eliminating cancer cells. Composite nanoparticles, magnetic 
nanoparticles encapsulated in biodegradable polymer matrix, for magnetic targeted 
drug delivery or folic acid-mediated cancer cell targeting were prepared and 
evaluated. A new PEGylation technique, ATRP, was exploited to minimize the 
nanoparticle uptake by the macrophage cells. The PEGylated particles can potentially 
be used as MRI contrast agent for diagnosing cancer cells in vivo after further 
functionalization with targeting agents. The results are summarized below: 
In the first part of the research, P4VP/PVDF microbeads (~500 µm) were successfully 
prepared using the phase inversion technique. The pyridine groups on the surface of 
the microbeads were then quaternized with alkyl bromides. The microbeads with 
spherical shape and narrow particle distribution possess effective antibacterial and 
antifungal properties. The beads N-alkylated with C4 and C6 chains have a high 
surface concentration of pyridinium groups. As such an amount of beads of ~0.8 wt% 
of an E. coli suspension of 105 CFU/ml can result in almost 100% killing efficiency 
within 20 minutes. A larger amount of beads is required to achieve the same killing 
rate of A. niger spores due to the more resistant nature of the fungal wall. The leakage 
of intracellular constituents from the bacteria cells and fungal spores upon contact 
with the N-alkylated beads confirms the lysing of the cells. These polymeric 
microbeads with surface fuctionalized quaternary ammonium salt are highly stable, 




In the second part of the research, the investigations were targeted towards detecting 
and eliminating cancer cells. The majority of pharmacological agents readily penetrate 
all cell types and will be rather evenly distributed within the body after 
administration. As a result, one has to administer the drug in large quantities in order 
to maintain a therapeutic effect in a certain body compartment. In addition, under 
these circumstances, cytotoxic and/or antigenic drugs can become the cause of many 
negative side effects. To circumvent these problems, two types of composite magnetic 
nanoparticles were developed to selectively delivery drugs or cancer cell diagnosing 
regents to target organs. 
The first type of composite nanoparticles, TMCN, with encapsulated magnetic 
nanoparticles and an anti-estrogen modulator, tamoxifen, were developed for 
magnetic targeted delivery. The TMCN with a particle size of ~200 nm were 
synthesized with solvent evaporation/extraction technique. The magnetic property of 
the TMCN was provided by the 6 nm superparamagnetic nanoparticles evenly 
distributed in the TMCN. The as-synthesized magnetic nanoparticles are 
superparamagnetic and have sufficient  magnetization for magnetic targeting. The 
TMCN can be readily taken in by MCF-7 cells and 182 pg TMCN was internalized 
into each MCF-7 cell over a 4 h incubation period with 500 µg TMCN/ml culture 
medium resulting in a decrease of cell viability to 20%. These results indicate that the 
TMCN have good potential as a carrier for the targeted release of tamoxifen. 
The second type of composite nanoparticles with encapsulated magnetic nanoparticles, 
and surface functionalized with folic acid were developed for folic acid-mediated 
cancer targeting. The folic acid on the composite particle surface was used as a 
targeting agent, and magnetic nanoparticles encapsulated in the composite 
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nanoparticles were used as the MRI contrast agent. For this work, a new polymer with 
a molecular weight of ~27k, PLLA-b-PPEGMA, was successfully prepared with a 
double-headed initiator, HMBP. The PLLA-b-PPEGMA was used to encapsulate 
magnetic nanoparticles via a solvent evaporation/extraction technique. These 
nanoparticles were then surface functionalized with folic acid. The in vitro tests show 
that MCF-7 cancer cells take much more folic acid functionalized composite 
nanoparticles than those without folic acid functionalization. The uptake of the 
composite nanoparticles with and without folic acid functionalization by RAW 264.7 
cells is much lower than that of folic acid functionalized composite nanoparticles by 
MCF-7 cancer cells. These results demonstrate the effectiveness of the surface 
immobilized folic acid in targeting the MCF-7 cells. The surface of the PLLA-b-
PPEGMA nanoparticles can be similarly functionalized with other targeting ligands 
besides folic acid, and they have good potential to become an effective carrier for 
targeted drug delivery in cancer treatment. 
The last part of the research was directed towards the minimization of the uptake of 
magnetic nanoparticles by macrophage cells. PEGMA was successfully grafted onto 
the magnetic nanoparticles surface via surfaced initiated ATRP. The grafted 
PPEGMA chains make the modified magnetic nanoparticles hydrophilic and the 
uptake of nanoparticles by the macrophage cells was greatly reduced from 158 pg/cell 
to <2 pg/cell after grafting with PPEGMA. This method provides opportunities for 
grafting a dense layer of hydrophilic polymer brushes onto the magnetic nanoparticles 
surface, and the PEGylated magnetic nanoparticles can be used as a contrast agent and 















Based on the investigations carried out in this PhD work, the following 
recommendations are put forth for further study related to this topic: 
Biodegradable nanoparticles for regulating the release of the 
antibiotic in bone cements 
Infections by bacteria are a serious complication following orthopedic implant 
surgery. These can usually only be cured by removing the implant, since the biofilm 
mode of growth of the infecting bacteria on an implant surface protects the organisms 
from the host immune system and antibiotic therapy. Over the past few decades, 
attempts have been made to prevent and treat orthopedic implant infections by 
incorporating antibiotics in polymethylmethacrylate (PMMA) bone cements. 
However, a low release efficiency of the antibiotics incorporated in bone cements was 
reported. In vitro studies indicate that only 5–8% of the antibiotic incorporated in an 
acrylic matrix is eventually released after a long time (Chohfi et al. 1998; Penner et al. 
1999; van de Belt et al. 2000; van de Belt et al. 2001). Several observations indicate 
that antibiotic release is a surface phenomenon. Incorporating biodegradable 
polymeric nanoparticles with antibiotics encapsulated could be used to increase the 
release efficiency of the antibiotics in biodegradable polymeric. The antibiotics, such 
as norfloxacin, can be encapsulated in PLLA polymeric nanoparticles with the solvent 
evaporation/extraction technique used in Section 4.2.2. The degradation of the PLLA 
polymer makes channels in the bone cement for the release of antibiotics. By using 
nanoparticles, the mechanical properties of the bone cement would not be 
significantly affected upon degradation of these nanoparticles. The burst release of the 








Surface functionalized magnetic nanoparticles with PEG by layer-by-
layer techniques 
In Chapter 6, the PPEGMA polymers were attached to the surfaces Fe3O4 
nanoparticles through the linker molecule — the initiator, [4-(chloromethyl) 
phenyl]trichlorosilane. Another promising techniques for the surface functionalization 
of Fe3O4 nanoparticles is the layer-by-layer (LBL) self-assembly method. Although 
the LBL is a non-covalent method, stable LBL functionalized surface can be achieved 
with suitable polyelectrolytes. The LBL method is much easier to handle than the 
surface initiated polymerization technique. A proposed scheme for functionalization 










The first step is to make the oleic acid coated hydrophobic Fe3O4 nanoparticles water 




































nanoparticles with a bipolar molecule, tetramethylammonium 11-aminoundecanoate, 
as the first layer. Shaking a hexane dispersion of Fe3O4 nanoparticles with a 
suspension of tetramethylammonium 11-aminoundecanoate in dicholoromethane will 
render the Fe3O4 nanoparticles water-soluble and positively charged. The second step 
is to coat the Fe3O4 nanoparticles with a layer of block polymer with PEG on one end 
and anionic polyelectrolytes on the other end, such as poly(γ-benzyl-L-glutamic acid)-
block-poly(ethylene glycol) (PBLG-PEG). 
In vivo distribution of the PEG functionalized magnetic nanoparticles 
by MRI 
In Chapter 4 and Chapter 6, we used in vitro methods to study the uptake of the PEG 
functionalized magnetic nanoparticles by macrophage cells and cancer cells. But for 
in vivo applications, the nanoparticles will experience much more complex 
environments than those we have tested in vitro. In future research, the fate of these 
PEG functionalized magnetic nanoparticles in vivo should be investigated using 
animal models (Bulte et al. 1999b). The blood clearance of the nanoparticles can be 
determined from the blood samples taken from the artery after injection of the 
functionalized nanoparticles. The biodistribution of the PEG functionalized 
nanoparticles can be visualized with the MRI as these superparamagnetic 
nanoparticles act as MRI contrast agent. The MRI results can also be compared with 
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